WO2002073605A2 - Essai biologique a deux perles utilisant des espaceurs clivables et/ou la ligature pour ameliorer la specificite et la sensibilite, procedes et dispositifs associes - Google Patents

Essai biologique a deux perles utilisant des espaceurs clivables et/ou la ligature pour ameliorer la specificite et la sensibilite, procedes et dispositifs associes Download PDF

Info

Publication number
WO2002073605A2
WO2002073605A2 PCT/US2002/008208 US0208208W WO02073605A2 WO 2002073605 A2 WO2002073605 A2 WO 2002073605A2 US 0208208 W US0208208 W US 0208208W WO 02073605 A2 WO02073605 A2 WO 02073605A2
Authority
WO
WIPO (PCT)
Prior art keywords
capture
beads
bead
disc
reporter
Prior art date
Application number
PCT/US2002/008208
Other languages
English (en)
Other versions
WO2002073605A3 (fr
Inventor
Kary Banks Mullis
Brigitte Chau Phan
Jorma Antero Virtanen
Original Assignee
Burstein Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/911,253 external-priority patent/US20020106661A1/en
Priority claimed from US09/997,741 external-priority patent/US20030003464A1/en
Priority claimed from US10/038,297 external-priority patent/US20030077598A1/en
Application filed by Burstein Technologies, Inc. filed Critical Burstein Technologies, Inc.
Priority to AU2002306750A priority Critical patent/AU2002306750A1/en
Publication of WO2002073605A2 publication Critical patent/WO2002073605A2/fr
Publication of WO2002073605A3 publication Critical patent/WO2002073605A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/01—Arrangements or apparatus for facilitating the optical investigation
    • G01N21/03—Cuvette constructions
    • G01N21/07—Centrifugal type cuvettes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/50273—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means or forces applied to move the fluids

Definitions

  • the present invention relates to optical analysis discs, optical bio-discs, medical CDs, and related methods and drive systems.
  • the invention further relates to dual bead assays using ligation and/or cleavable spacers to improve specificity and sensitivity.
  • the present assays and methods are performed by employing optical bio-discs and related system apparatus.
  • the assays and methods utilizing magnetic or metal beads may be implemented on a magneto-optical bio-disc.
  • the present invention relates to performing assays, and particularly to using dual bead structures on a disc.
  • the invention includes methods for preparing assays, methods for performing assays, discs for performing assays, and related detection systems.
  • the present invention includes methods for determining whether a target agent is present in a biological sample.
  • These methods can include mixing capture beads, each having at least one transport probe, reporter beads, each having at least one signal probe, and a biological sample. These components are mixed under binding conditions that permit formation of a dual bead complex if the target agent is present in the sample.
  • the dual bead complex thus includes a reporter bead and a capture bead each bound to the target agent.
  • the dual bead complex is isolated from the mixture to obtain an isolate.
  • the isolate is then exposed to a capture field on an optical disc.
  • the capture field has a capture agent that binds specifically to the signal probe or transport probe of the dual bead complex.
  • the dual bead complex in the optical disc is then detected to indicate that the target agent is present in the sample and, if desired, to indicate a concentration.
  • the capture beads can have a specified size and have a characteristic that makes them "isolatable".
  • the capture beads are preferably magnetic, in which case the isolating of dual bead complex (and some capture beads not part of a complex) in a mixture includes subjecting the mixture to a magnetic field with a permanent magnet, an electromagnet, or a magnetic array of capture areas written on a magneto-optical disc according to certain aspects of the present invention.
  • the reporter bead should have characteristics that make it identifiable and distinguishable with detection.
  • the reporter beads can be made of one of a number of materials, such as latex, gold, plastic, steel, or titanium, and should have a known and specified size.
  • the reporter beads can be fluorescent and can be yellow, green, red, or blue, for example.
  • the dual bead complex can be formed on the disc itself, or outside the disc and added to the disc.
  • methods referred to here as “single-step” or “two-step” can be employed.
  • the mixture initially includes capture beads and the sample.
  • the capture beads are then isolated to wash away unbound sample and leave bound and unbound capture beads in a first isolate.
  • Reporter beads are then added to the first isolate to produce dual bead complex structures and the isolation process is repeated.
  • the resulting isolate leaves dual bead complex with reporters, but also includes unbound capture beads without reporters. The reporters make the dual bead complex detectable.
  • the capture beads, reporter beads, and sample are mixed together from the start and then the isolation process isolates dual bead complex along with unbound capture beads.
  • the sample and beads can be added to the disc together, or the beads can be pre-loaded on the disc so that only a sample needs to be added.
  • the sample and beads can be added in a mixing chamber on the disc, and the disc can be rotated in one direction or in both to assist the mixing.
  • An isolate can then be created, such as by applying an electromagnet and rotating to cause the material other than the capture beads to be moved to a waste chamber. The isolate is then directed through rotation to capture fields.
  • the dual bead complex structures can be detected on the capture field by use of various methods.
  • the detecting includes directing a beam of electromagnetic energy from a disc drive toward the capture field and analyzing electromagnetic energy returned from or transmitted past the reporter bead of the dual bead complex attached to the capture field.
  • the disc drive assembly can include a detector and circuitry or software that senses the detector signal for a sufficient transition between light and dark (referred to as an "event") to spot a reporter bead.
  • the energy source in the disc drive preferably has a wavelength controllable light source and a detector that is or can be made specific to a particular wavelength.
  • a disc drive can be made with a specific light source and detector to produce a dedicated device, in which case the source may only need fine-tuning.
  • the biological sample can include blood, serum, plasma, cerebrospinal fluid, breast aspirate, synovial fluid, pleural fluid, perintoneal fluid, pericardial fluid, urine, saliva, amniotic fluid, semen, mucus, a hair, feces, a biological particulate suspension, a single-stranded or double-stranded nucleic acid molecule, a cell, an organ, a tissue, or a tissue extract, or any other sample that includes a target that may be bound through chemical or biological processes. Further details relating to other aspects associated with the selection and detection of various targets is disclosed in, for example, commonly assigned co-pending U.S. Provisional Patent Application Serial No. 60/278,697 entitled "Dual Bead Assays for Detecting Medical Targets" filed March 26, 2001 , which is incorporated herein by reference in its entirety.
  • the embodiments of the present invention can be used in other ways, such as for testing for impurities in a sample, such as food or water, or for otherwise detecting the presence of a material, such as a biological warfare agent.
  • the target agent can include, for example, a nucleic acid (such as DNA or RNA) or a protein (such as an antigen or an antibody). If the target agent is a nucleic acid, both the transport probe and the signal probe can be a nucleic acid molecule complementary to the target nucleic acid. If the target agent is a protein, both the transport probe and the signal probe can be an antibody that specifically binds the target protein.
  • a nucleic acid such as DNA or RNA
  • a protein such as an antigen or an antibody
  • the transport probe or signal probe can specifically bind to the capture agent on the optical disc due to a high affinity between the probe and the capture agent.
  • This high affinity can, for example, be the result of a strong protein-protein affinity (i.e., antigen-antibody affinity), or the result of a complementarity between two nucleic acid molecules.
  • the target agent binds to the signal probe, and then the disc is rotated to move unbound structures, including capture beads not bound to reporter beads, away from the capture field. If the target agent binds to the transport probe, unbound capture beads will be included, although the reporter beads are still the beads that are detected. This may be acceptable if the detection is for producing a yes/no answer, or if fine concentration detection is not otherwise required.
  • the transport probe and signal probe can each be one or more probes selected from the group consisting of single-stranded DNA, double-stranded DNA, single-stranded RNA, peptide nucleic acid, biotin, streptavidin, an antigen, an antibody, a receptor protein, and a ligand.
  • each transport probe includes double-stranded DNA and single-stranded DNA, wherein the double- stranded DNA is proximate to the capture layer of the optical disc and the single- stranded DNA is distal relative to the capture layer of the optical disc.
  • the reporter bead and/or signal probe can be biotinylated and the capture agent can include streptavidin or Neutravidin.
  • the capture agent can be affixed to the capture layer by use of an amino group or a thiol group.
  • the target agent can include a nucleic acid characteristic of a disease, or a nucleotide sequence specific for a person, or a nucleotide sequence specific for an organism, which may be a bacterium, a virus, a mycoplasm, a fungus, a plant, or an animal.
  • the target agent can include a nucleic acid molecule associated with cancer in a human.
  • the target nucleic acid molecule can include a nucleic acid, which is at least a portion of a gene selected from the group consisting of HER2neu, p52, p53, p21, and bcl-2.
  • the target agent can be an antibody that is present only in a subject infected with HIV-1 , a viral protein antigen, or a protein characteristic of a disease state in a subject.
  • the methods and apparatus of the present invention can be used for determining whether a subject is infected by a virus, whether nucleic acid obtained from a subject exhibits a single nucleotide mutation (SNM) relative to corresponding wild-type nucleic acid sequence, or whether a subject expresses a protein of interest, such as a bacterial protein, a fungal protein, a viral protein, an HIV protein, a hepatitis C protein, a hepatitis B protein, or a protein known to be specifically associated with a disease.
  • SNM single nucleotide mutation
  • multiplexing methods wherein more than one target agent (e.g., tens, hundreds, or even thousands of different target agents) can be identified on one optical analysis disc.
  • Multiple capture agents can be provided in a single chamber together in capture fields, or separately in separate capture fields.
  • Different reporter beads can be used to be distinguishable from each other, such as beads that fluoresce at different wavelengths or different size reporter beads. Experiments were performed to identify two different targets using the multiplexing technique. An example of one such assay is discussed below in Example 2.
  • the invention includes an optical disc with a substrate, a capture layer associated with the substrate, and a capture agent bound to the capture layer, such that the capture agent binds to a dual bead complex.
  • Multiple different capture agents can be used for different types of dual bead complexes.
  • the disc can be designed to allow for some dual bead processing on the disc with appropriate chambers and fluidic structures, and can be pre-loaded with reporter and capture beads so that only a sample needs to be added to form the dual bead complex structures.
  • a disc and disc drive system for performing dual bead assays.
  • the disc drive can include an electromagnet for performing the isolation process, and may include appropriate light source control and detection for the type of reporter beads used.
  • the disc drive can be optical or magneto-optical.
  • the drive may advantageously include an electromagnet, and the disc preferably has a mixing chamber, a waste chamber, and capture area.
  • the sample is mixed with beads in the mixing chamber, a magnetic field is applied adjacent the mixing chamber, and the sample not held by the magnet is directed to the waste chamber so that all magnetic beads, whether bound into a dual bead complex or unbound, remain in the mixing chamber.
  • the magnetic beads are then directed to the capture area.
  • a bio-disc is produced for use with biological samples and is used in conjunction with a disc drive, such as a magneto-optical disc drive, that can form magnetic regions on a disc.
  • magnetic regions can be formed in a highly controllable and precise manner. These regions may be employed advantageously to magnetically bind magnetic beads, including unbound magnetic capture beads or including dual bead complexes with magnetic capture beads.
  • the magneto-optical disc drive can write to selected locations on the disc, and then use an optical reader to detect features located at those regions. The regions can be erased, thereby allowing the beads to be released.
  • a method of using a bio-disc and drive including forming magnetic regions on the bio-disc or medical CD.
  • This method includes providing magnetic beads to the discs so that the beads bind at the magnetic locations.
  • the method preferably further includes detecting at the locations where the magnetic beads bind biological samples, preferably using reporter beads that are detectable, such as by fluorescence or optical event detection.
  • the method can be formed in multiple stages in terms of time or in terms of location through the use of multiple chambers.
  • the regions are written to and a sample is moved over the magnetic regions in order to capture magnetic beads. The regions can then be erased and released if desired.
  • This method allows many different tests to be performed at one time, and can allow a level of interactivity between the user and the disc drives such that additional tests can be created during the testing process.
  • the dual bead assay according to the present invention may be implemented with magnetic capture beads and fluorescent reporter beads. These beads are coated with capture probes and reporter probes respectively. The capture probes and reporter probes are complementary to the target sequence but not to each other. The capture beads are mixed with varying quantities of target DNA. Unbound target is removed from the solution by magnetic concentration of the magnetic beads. Fluorescent reporter beads are then allowed to bind to the captured target DNA. Unbound reporter beads are removed by magnetic concentration of the magnetic beads. Thus, only in the presence of the target sequence, the magnetic capture beads bind to fluorescent reporter beads, resulting in a dual bead assay.
  • the capture and reporter probes are covalently conjugated onto carboxylated capture beads and reporter beads via EDC conjugation.
  • a number of different surface chemistries and different methods for binding the probes to the beads were investigated.
  • One observed result was non-covalent attachment of probes to beads.
  • This limitation was overcome by the development of a method for attaching double stranded probes to the beads and by selection of appropriate bead type.
  • the use of double stranded probes in the conjugation reduces the non-covalent attachment of probes to beads significantly.
  • the covalent conjugation efficiency is as high as 95%.
  • each target molecule will hybridize to one reporter bead. Due to its size, a single target molecule is not detectable by any existing technologies. However, a 1 ⁇ m or larger reporter bead can be easily detected and quantified by various methods. Therefore, the dual bead assay increases the sensitivity of the target capture tremendously.
  • specific binding of reporter beads can be detected by different methods. These methods include microscopic analysis, measurement of the fluorescent signal using a fluorimeter, or bead detection in an optical disc reader.
  • the first factor is high non-specific binding of the capture beads to the reporters in the absence of target DNA.
  • the second factor is the low target-mediated binding of reporter beads to capture beads. Numerous approaches were investigated to circumvent these obstacles.
  • Modifications to reduce the non-specific binding in the dual bead assays include the selection of bead types and mode of conjugation, bead pretreatments, selection of buffer and wash conditions, use of blocking agents. Further details relating thereto are provided in commonly assigned co-pending U.S. Patent Application Serial No. 10/087,549 entitled “Methods for Decreasing Non-Specific Binding of Beads in Dual Bead Assays Including Related Optical Biodiscs and Disc Drive Systems" filed February 28, 2002.
  • a modification has been introduced to increase the signal to noise ratio in the dual bead assay. This consists in strengthening the connection between the capture bead and reporter beads by covalent bonds.
  • the reporter beads are bound to the capture beads via the hydrogen bonds between the probes and the target DNA. If the number of hydrogen bonds is not sufficient, the shear forces resulting from mixing and washing will break the reporter beads from the capture beads, yielding a low reporter signal. We have shown that the number of hydrogen bonds between the target and probes is directly correlated with the number of reporter beads bound.
  • ligation is carried out to make a covalent bond between the capture probe and reporter probe.
  • the hydrogen bonds formed between the target and the capture and reporter probes allow the capture probes and reporter probes to be in close proximity, facilitating the ligation reaction.
  • the connection between the capture and reporter beads is now much stronger due to the covalent bond.
  • the use of magnetic beads in the capture of target DNA speeds up the washing steps and facilitates the separation steps between bound and unbound target DNA significantly.
  • the ligation reaction which strengthens the bond between the capture and reporter beads, eliminates the need for long probes and therefore improves the sensitivity of the dual bead assay significantly.
  • the ligation reaction could also be carried out if the capture probe or reporter probe is attached to the disc instead of the beads.
  • specific binding of reporter beads can be detected by different methods. These methods include microscopic analysis, measurement of the fluorescent signal using a fluorimeter or bead detection in an optical disc reader.
  • the dual bead assay according to the present invention may be quantified on a closed optical bio-disc.
  • the dual bead assay may first be carried out outside the disc.
  • a capture zone is created.
  • Two methods for immobilizing capture reagents on the open disc were investigated.
  • the first one consists in using BSA-biotin molecules to capture the Streptavidin-coated reporter beads.
  • the second method comprises the use of a DNA sequence complementary to the reporter probes to capture the reporter beads.
  • the disc surface is coated with a layer of polystyrene.
  • the capturing sequence is modified at the end with an amino group.
  • the disc surface is coated with maleic anhydride polystyrene.
  • the amino group on the probe binds covalently to the maleic anhydride, thereby attaching DNA capture probe to the disc in the capture zone. Unbound capture reagents are washed off. At this point, the channel is assembled by affixing adhesive and a cover disc or cap. The dual bead assay suspension is then loaded into the channels via the port such that the whole channel is filled with the sample. The ports are sealed and the disc is rotated in the disc drive assembly. During spinning, all free magnetic capture beads will be spun off to the bottom of the channel. Therefore, only the reporter beads (with or without the attaching magnetic capture beads) are captured within the capture zone, and the number of reporter beads can be quantified by the optical reader.
  • the present invention also involves implementing the methods recited above on an analysis disc, modified optical disc or a bio-disc.
  • a bio-disc drive assembly may be employed to rotate the disc, read and process any encoded information stored on the disc, and analyze the DNA samples in the flow channel of the bio-disc.
  • the bio-disc drive is thus provided with a motor for rotating the bio-disc, a controller for controlling the rate of rotation of the disc, a processor for processing return signals form the disc, and an analyzer for analyzing the processed signals.
  • the rotation rate of the motor is controlled to achieve the desired rotation of the disc.
  • the bio-disc drive assembly may also be utilized to write information to the bio-disc either before or after the test material in the flow channel and target zones is interrogated by the read beam of the drive and analyzed by the analyzer.
  • the bio-disc may include encoded information for controlling the rotation rate of the disc, providing processing information specific to the type of DNA test to be conducted, and for displaying the results on a monitor associated with the bio- drive.
  • the dual bead assay according to the present invention may be implemented by using, for example, 3 ⁇ m magnetic capture beads and 2.1 ⁇ m fluorescent reporter beads. These beads are coated with capture probes and reporter probes respectively.
  • the capture probes and reporter probes in addition to being complementary to the target sequence, contain sequences that are complementary to each other.
  • the sequences that bind the capture probe and the reporter probes together are designed such that they are susceptible to the cleavage of very rare restriction enzymes (such as Not 1).
  • the capture beads and reporter beads are mixed with varying quantities of target DNA.
  • the DNA complex is subjected to restriction digestion by the restriction enzyme (for example Not 1).
  • the restriction digestion by this enzyme will cleave the DNA sequence connecting the reporter beads to the capture beads.
  • the reporter beads will dissociate from the capture beads and be removed by magnetic concentration of the magnetic beads. Thus only in the presence of the target sequence, will the magnetic capture beads bind to fluorescent reporter beads to thereby result in a dual bead assay.
  • This first method includes the steps of preparing a dual bead complex including at least one reporter bead and at least one capture bead. The beads are linked together by a cleavable spacer. This method also includes the steps of mixing the dual bead complex with a biological sample to be tested for a target, allowing any target present in the sample to form an association with the dual bead complex, and cleaving the cleavable spacers of the dual bead complexes so that only complexes associated with the target remain in the dual bead formation.
  • the method may continue with the steps of isolating the remaining dual bead complexes from solution to obtain an isolate, exposing the isolate to a capture field on an optical bio-disc, and detecting the presence of the dual bead complex in the disc to indicate that the target is present in the sample.
  • the capture field is advantageously provided with a capture agent that binds to the dual bead complex.
  • the cleavable spacer includes at least one transfer probe and at least one reporter probe.
  • the capture bead may have at least one transport probe, and the reporter bead may preferably have at least one signal probe.
  • the mixing step is performed in the disc.
  • the capture bead has at least one transport probe and the reporter bead has at least one signal probe.
  • the present method may advantageously include the further step of performing a ligation reaction to introduce a covalent bond between the transport probe and the signal probe to thereby strengthen the bond between the capture bead and the reporter bead.
  • a method using a displaceable member to identify whether a target is present in a biological sample includes the steps of (1) preparing a dual bead complex including at least one reporter bead and at least one capture bead, the beads being linked together by a displaceable spacer; (2) mixing the dual bead complex with a biological sample to be tested for a target; (3) allowing any target present in the sample to form an association with the dual bead complex; and (4) displacing the displaceable spacers of the dual bead complexes so that only complexes associated with the target remain in the dual bead formation.
  • This method may conclude with the further steps of (5) isolating the remaining dual bead complexes from solution to obtain an isolate; (6) exposing the isolate to a capture field on an optical bio-disc, the capture field having a capture agent that binds to the dual bead complex; and (7) detecting the presence of the dual bead complex in the disc to indicate that the target is present in the sample.
  • the capture bead has at least one transport probe
  • the reporter bead may preferably include at least one signal probe.
  • the mixing step of the present method may be performed in the disc.
  • the capture bead has at least one transport probe and the reporter bead has at least one signal probe.
  • the method may preferably include the further step of performing a ligation reaction to introduce a covalent bond between the transport probe and the signal probe to thereby strengthen the bond between the capture bead and the reporter bead.
  • the displacing step may be preformed by use of a displacement probe.
  • a method using ligation to identify whether a target is present in a biological sample includes the main steps of (1 ) preparing a plurality of capture beads each of having at least one transport probe affixed thereto; (2) preparing a plurality of reporter beads each having at least one signal probe affixed thereto; and (3) mixing the capture beads, the reporter beads, and a sample to be tested for the presence of a target.
  • This method concludes with the steps of (4) allowing any target present in the sample to bind to the transport and reporter probes thereby forming a dual bead complex including at least one reporter bead and one capture bead; and (5) performing a ligation reaction to introduce a covalent bond between the transport probes and the reporter probes to thereby strengthen the bond between the capture bead and the reporter bead so that when the dual bead complexes are processed in a fluidic circuit of a rotating optical bio- disc, the strengthened bond withstands any rotational forces acting thereon.
  • the mixing, allowing, and performing steps may be preferably carried out in the optical bio- disc.
  • the above dual bead ligation method may advantageously also include the further steps of (1) isolating the dual bead complex from solution to obtain the isolate; (2) exposing the isolate to a capture field on an optical bio-disc, the capture field having a capture agent that binds to the dual bead complex; and (3) detecting the presence of the dual bead complex in the disc to indicate that the target agent is present in the sample.
  • the isolating, exposing, and detecting steps may be performed in association with the optical bio- disc.
  • an optical bio-disc adapted to implement any of the methods discussed above.
  • This optical bio-disc includes a substrate having encoded information associated therewith. The encoded information is readable by a disc drive assembly to control rotation of the disc.
  • the disc is provided with a target zone associated with the substrate. The target zone is disposed at a predetermined location relative to the substrate.
  • An active layer is provided in association with the target zone.
  • a plurality of capture agents are attached to the active layer so that when the bio-disc is rotated, the capture agents remain attached to the active layer to thereby maintain a number of the capture agents within the target zone. In this manner, when a dual bead complex is introduced into the target zone, the capture agent sequesters the dual bead complex therein to thereby allow detection of captured dual bead complexes.
  • the various embodiments of the apparatus and methods of the present invention can be designed for use by an end-user, inexpensively, without specialized expertise and expensive equipment.
  • the system can be made portable, and thus usable in remote locations where traditional diagnostic equipment may not generally be available.
  • Other related aspects applicable to components of this assay system and signal acquisition methods are disclosed in commonly assigned and co-pending U.S. Patent Application Serial No. 10/038,297 entitled “Dual Bead Assays Including Covalent Linkages For Improved Specificity And Related Optical Analysis Discs" filed January 4, 2002; U.S. Provisional Application Serial No. 60/272,525 entitled "Biological Assays Using Dual Bead Multiplexing Including Optical Bio-Disc and Related Methods” filed March 1 , 2001 ; and U.S.
  • Provisional Application Serial Nos. 60/275,643, 60/314,906, and 60/352,270 each entitled "Surface Assembly for Immobilizing Capture Agents and Dual Bead Assays Including Optical Bio-Disc and Methods Relating Thereto” respectively filed March 14, 2001 , August 24, 2001 , and January 30, 2002. All of these applications are herein incorporated by reference in their entirety.
  • Fig. 1 is a perspective view of an optical disc system according to the present invention
  • Fig. 2 is a block and pictorial diagram of an optical reading system according to embodiments of the present invention
  • Figs. 3A, 3B, and 3C are respective exploded, top, and perspective views of a reflective disc according to embodiments of the present invention.
  • Figs. 4A, 4B, and 4C are respective exploded, top, and perspective views of a transmissive disc according to embodiments of the present invention.
  • Fig. 5A is a partial longitudinal cross sectional view of the reflective optical bio- disc shown in Figs. 3A, 3B, and 3C illustrating a wobble groove formed therein;
  • Fig. 5B is a partial longitudinal cross sectional view of the transmissive optical bio-disc illustrated in Figs. 4A, 4B, and 4C showing a wobble groove formed therein and a top detector;
  • Fig. 6A is a partial radial cross-sectional view of the disc illustrated in Fig. 5A;
  • Fig. 6B is a partial radial cross-sectional view of the disc illustrated in Fig. 5B;
  • Figs. 7A, 8A, 9A, and 10A are schematic representations of a capture bead, a reporter bead, and a dual bead complex as utilized in conjunction with genetic assays;
  • Figs. 7B, 8B, 9B, and 10B are schematic representations of a capture bead, a reporter bead, and a dual bead complex as employed in conjunction with immunochemical assays;
  • Fig. 11A is a pictorial representation of one embodiment of a method for producing genetic dual bead complex solutions
  • Fig. 11 B is a pictorial representation of one embodiment of a method for producing immunochemical dual bead complex solutions
  • Fig. 12A is a pictorial representation of another embodiment of a method for producing genetic dual bead complex solutions
  • Fig. 12B is a pictorial representation of another embodiment of a method for producing immunochemical dual bead complex solutions
  • Fig. 13 is a longitudinal cross sectional view illustrating the disc layers in combination with a mixing or loading chamber
  • Fig. 14 is a view similar to Fig. 13 showing the mixing chamber loaded with dual bead complex solution;
  • Figs. 15A and 15B are radial cross sectional views of the disc and target zone illustrating one embodiment for binding of reporter beads to capture agents in a genetic assay;
  • Figs. 16A and 16B are radial cross sectional views of the disc and target zone showing another embodiment for binding of reporter beads to capture agents in a genetic assay;
  • Fig. 17 is radial cross sectional view of the disc and target zone illustrating one embodiment for binding of capture beads to capture agents in a genetic assay
  • Fig. 18 is radial cross sectional view of the disc and target zone depicting another embodiment for binding of capture beads to capture agents in a genetic assay
  • Figs. 19A, 19B, and 19C are partial cross sectional views illustrating one embodiment of a method according to this invention for binding the reporter bead of a dual bead complex to a capture layer in a genetic assay;
  • Figs. 20A, 20B, and 20C are partial cross sectional views showing one embodiment of a method according to the present invention for binding the reporter bead of a dual bead complex to a capture layer in a immunochemical assay;
  • Figs. 21 A, 21 B, and 21 C are partial cross sectional views illustrating another embodiment of a method according to this invention for binding the reporter bead of a dual bead complex to a capture layer in a genetic assay;
  • Figs. 22A, 22B, and 22C are partial cross sectional views presenting another embodiment of a method according to the invention for binding the reporter bead of a dual bead complex to a capture layer in a immunochemical assay;
  • Figs. 23A and 23B are partial cross sectional views depicting one embodiment of a method according to the present invention for binding the capture bead of a dual bead complex to a capture layer in a genetic assay;
  • Figs. 24A and 24B are partial cross sectional views showing another embodiment of a method according to this invention for binding the capture bead of a dual bead complex to a capture layer in a genetic assay;
  • Figs. 25A-25D illustrate a method according to the present invention for detecting the presence of target DNA or RNA in a genetic sample utilizing an optical bio-disc;
  • Figs. 26A-26D illustrate another method according to this invention for detecting the presence of target DNA or RNA in a genetic sample utilizing an optical bio-disc
  • Figs. 27A-27D illustrate a method according to the present invention for detecting the presence of a target antigen in a biological test sample utilizing an optical bio-disc
  • Fig. 28A is a graphical representation of an individual 2.1 micron reporter bead and a 3 micron capture bead positioned relative to the tracks of an optical bio- disc according to the present invention
  • Fig. 28B is a series of signature traces derived from the beads of Fig. 28A utilizing a detected signal from the optical drive according to the present invention
  • Fig. 29A is a graphical representation of a 2.1 micron reporter bead and a 3 micron capture bead linked together in a dual bead complex positioned relative to the tracks of an optical bio-disc according to the present invention
  • Fig. 29B is a series of signature traces derived from the dual bead complex of Fig. 29A utilizing a detected signal from the optical drive according to this invention
  • Fig. 30A is a bar graph showing results from a dual bead assay according to the present invention
  • Fig. 30B is a graph showing a standard curve demonstrating the detection limit for fluorescent beads detected with a flourimeter
  • Fig. 30C is a pictorial representation demonstrating the formation of the dual bead complex
  • Fig. 31 is a bar graph showing the sensitivity of disc drive detection using a dual bead complex
  • Fig. 32 is a schematic representation of combining beads for dual bead assay multiplexing according to embodiments of the present invention.
  • Fig. 33A is a schematic representation of a fluidic circuit according to the present invention utilized in conjunction with a magnetic field generator to control movement of magnetic beads;
  • Figs. 33B-33D are schematics of a first fluidic circuit that implements the valving structure of FIG. 33A according to one embodiment of fluid transport aspects of the present invention
  • Figs. 34A-34C are schematics of a second fluidic circuit that implements the valving structure of FIG. 33A according to another embodiment of the fluid transport aspects of this invention
  • Fig. 35 is a perspective view of the magnetic field generator and a disc including one embodiment of a fluidic circuit employed in conjunction with magnetic beads according to this invention
  • Figs. 36A, 36B, and 36C are plan views illustrating a method of separation and detection for dual bead assays using the fluidic circuit shown in Fig. 35;
  • Fig. 37 is a perspective view of a magneto-optical bio-disc showing magnetic regions, magnetically bound capture beads, and the formation of dual bead complexes according to another aspect of the present invention
  • Fig. 38 shows the use of ligation to form a covalent bond between the capture and reporter probes
  • Fig. 39 is a bar graph showing the results from a genetic test detected by an enzyme assay in a ligation experiment
  • Fig. 40 is a bar graph comparing the number of beads bound as a function of target concentration using 2.1 ⁇ m reporter beads with and without ligation
  • Fig. 41 is a bar graph comparing the number of beads bound as a function of target concentration using a 39mer bridge with and without ligation;
  • Fig. 42A is schematic representation of various probe structures including DNA sequences for use in a dual bead complex employing cleavable or displaceable spacers according to the present invention
  • Fig. 42B is pictorial diagrammatic representation showing a cleavable spacer connecting a dual bead complex prior to binding of a target;
  • Fig. 42C is a view similar or Fig. 42B illustrating the cleavable spacer including a Notl connecting the dual bead complex after target binding;
  • Fig. 42D is a view similar to Fig. 42C depicting the dual bead complex after target binding and after cleavage by Notl;
  • Fig. 43A is pictorial diagrammatic representation showing a displaceable spacer connecting a dual bead complex prior to binding of a target
  • Fig. 43B is a view similar to Fig. 43A illustrating initial binding of a displacement probe to the displaceable spacer connecting the dual bead complex after target binding;
  • Fig. 43C is a view similar to Fig. 43B depicting complete displacement of the displacement probe connecting the dual bead complex in the presence of target mediated binding;
  • Fig. 44 is a pictorial representation of cleavable spacers covalently attached to a capture according to the present invention.
  • Fig. 45 is a view similar to Fig. 44 showing thiol groups attached to the cleavable spacers binding covalently to a metallic reporter bead;
  • Fig. 46A is a pictorial representation of a pair of dual bead complexes bound together by a cleavable spacer before target binding;
  • Fig. 46B is a view similar to Fig. 46A showing the dual bead complexes bound together by the cleavable spacer after target binding and without target binding;
  • Fig. 46C is a view similar to Fig. 46B showing one of the dual bead complexes dissociated after enzyme cleavage and the other held together by the presence of the target;
  • Fig. 47A is a pictorial presentation of a dual bead complex formed by a pair of cleavable spacers and use of a bridge bound to a target;
  • Fig. 47B is a view similar to Fig. 47A after target binding including the bridge resulting in a double helix containing two breaks;
  • Fig. 47C is a view similar to Fig. 47B after restriction digestion of the cleavable spacers and ligation of the breaks in the double helix;
  • Fig. 48A pictorial representation of two dual bead complexes each joined together by a pair of cleavable spacers as implemented in an immunochemical assay prior to target antigen binding;
  • Fig. 48B is a view similar to Fig. 48A showing the dual bead complexes bound together by the cleavable spacer with and without target binding;
  • Fig. 48C is a view similar to Fig. 48B illustrating one of the dual bead complexes dissociated after enzyme digestion and the other held together by the presence of the target.
  • the following description of the present invention relates to optical analysis discs, disc drive systems, and assay chemistries and techniques.
  • the invention further relates to alternate magneto-optical drive systems, MO bio-discs, and related processing methods.
  • Disc Drive System and Related Optical Analysis Discs With reference now to Fig. 1 , there is shown a perspective view of an optical analysis disc, optical bio-disc, or medical CD 1 10 for use in an optical disc drive 1 12.
  • Drive 112 in conjunction with software in the drive or associated with a separate computer, can cause images, graphs, or output data to be displayed on display monitor 114.
  • the disc drive can be in a unit separate from a controlling computer, or provided in a bay within a computer.
  • the device can be made as portable as a laptop computer, and thus usable with battery power and in remote locations not generally served by advanced diagnostic equipment.
  • the drive is preferably a conventional drive with minimal or no hardware modification, but can be a dedicated bio-disc or medical CD drive. Further details regarding these types of drive systems and related signal processing methods are disclosed in, for example, commonly assigned and co-pending U.S. Patent Application Serial No. 09/378,878 entitled “Methods and Apparatus for Analyzing Operational and Non-operational Data Acquired from Optical Discs” filed August 23, 1999; U.S. Provisional Patent Application Serial No. 60/150,288 entitled “Methods and Apparatus for Optical Disc Data Acquisition Using Physical Synchronization Markers” filed August 23, 1999; U.S. Patent Application Serial No.
  • Optical bio-disc 110 for use with embodiments of the present invention may have any suitable shape, diameter, or thickness, but preferably is implemented on a round disc with a diameter and a thickness similar to those of a compact disc (CD), a recordable CD (CD-R), CD-RW, a digital versatile disc (DVD), DVD-R, DVD-RW, or other standard optical disc format.
  • CD compact disc
  • CD-R recordable CD
  • DVD digital versatile disc
  • the disc may include encoded information, preferably in a known format, for performing, controlling, and post-processing a test or assay, such as information for controlling the rotation rate and direction of the disc, timing for rotation, stopping and starting, delay periods, locations of samples, position of the light source, and power of the light source.
  • encoded information is referred to generally here as operational information.
  • the disc may be a reflective disc, as shown in Figs. 3A-3C, a transmissive disc, Figs. 4A-4C, or some combination of reflective and transmissive.
  • a reflective disc an incident light beam is focused onto the disc (typically at a reflective surface where information is encoded), reflected, and returned through optical elements to a detector on the same side of the disc as the light source.
  • a transmissive disc light passes through the disc (or portions thereof) to a detector on the other side of the disc from the light source.
  • some light may also be reflected and detected as reflected light.
  • Fig. 2 shows an optical disc reader system 1 16.
  • This system may be a conventional reader for CD, CD-R, DVD, or other known comparable format, a modified version of such a drive, or a completely distinct dedicated device.
  • the basic components are a motor for rotating the disc, a light system for providing light, and a detection system for detecting light.
  • a light source 118 provides light to optical components 120 to produce an incident light beam 122.
  • a return beam 124 is reflected from either reflective surface 156, 174, or 186, Figs. 3C and 4C. Return beam 124 is provided back to optical components 120, and then to a bottom detector 126.
  • the return beam may carry operational information or other encoded data as well as characteristic information about the investigational feature or test sample under study.
  • transmissive disc 180 For transmissive disc 180, Figs. 4A-4C, some of the energy from the incident beam 122 will undergo a light/matter interaction with an investigational feature or test sample and then proceed through the disc as a transmitted beam 128 that is detected by a top detector 130.
  • a transmissive disc including a semi-reflective layer 186 (Fig. 4C) as the operational layer some of the energy from the incident beam 122 will also reflect from the operational layer as return beam 124, which carries operational information or stored data.
  • Optical components 120 can include a lens, a beam splitter, and a quarter wave plate that changes the polarization of the light beam so that the beam splitter directs a reflected beam through the lens to focus the reflected beam onto the detector.
  • An astigmatic element such as a cylindrical lens, may be provided between the beam splitter and detector to introduce astigmatism in the reflected light beam.
  • the light source can be controllable to provide variable wavelengths and power levels over a desired range in response to data introduced by the user or read from the disc. This controllability is especially useful when it is desired to detect multiple different structures that fluoresce at different wavelengths.
  • a computer 132 including a processor 134 and an analyzer 136.
  • An image or output results can then be provided to a monitor 114.
  • Computer 132 can represent a desktop computer, programmable logic, or some other processing device, and also can include a connection (such as over the Internet) to other processing and/or storage devices.
  • a drive motor 140 and a controller 142 are provided for controlling the rotation rate and direction or rotation of disc the 144 or 180. Controller 142 and the computer 132 with processor 134 can be in remote communication or implemented in the same computer. Methods and systems for reading such a disc are also shown in Gordon, U.S. Patent No. 5,892,577, which is incorporated herein by reference.
  • the detector can be designed to detect all light that reaches the detector, or though its design or an external filter, light only at specific wavelengths. By making the detector controllable in terms of the detectable wavelength, beads or other structures that fluoresce at different wavelengths can be separately detected.
  • a hardware trigger sensor 138 may be used with either a reflective disc 144 or transmissive disc 180. Triggering sensor 138 provides a signal to computer 132 (or to some other electronics) to allow for the collection of data by processor 134 only when incident beam 122 is on a target zone or inspection area. Alternatively, software read from a disc can be used to control data collection by processor 134 independent of any physical marks on the disc. Such software or logical triggering is discussed in further detail in commonly assigned and co-pending U.S. Provisional Application Serial No. 60/352,625 entitled "Logical Triggering Methods And Apparatus For Use With Optical Analysis Discs And Related Disc Drive Systems" filed January 28, 2002, which is herein incorporated by reference in its entirety.
  • the substrate layer of the optical analysis disc may be impressed with a spiral track that starts at an innermost readable portion of the disc and then spirals out to an outermost readable portion of the disc.
  • this track is made up of a series of embossed pits with varying length, each typically having a depth of approximately one-quarter the wavelength of the light that is used to read the disc.
  • the varying lengths and spacing between the pits encode the operational data.
  • the spiral groove of a recordable CD-like disc has a detectable dye rather than pits. This is where the operation information, such as the rotation rate, is recorded.
  • the rotation rate may be variable with intervening or consecutive periods of acceleration, constant speed, and deceleration.
  • the disc drive assembly is thus employed to rotate the disc, read and process any encoded operational information stored on the disc, and analyze the liquid, chemical, biological, or biochemical investigational features in an assay region of the disc.
  • the disc drive assembly may be further utilized to write information to the disc either before, during, or after the material in the assay zone is analyzed by the read beam of the drive.
  • the disc drive assembly is implemented to deliver assay information through various possible interfaces such as via Ethernet to a user, over the Internet, to remote databases, or anywhere such information could be advantageously utilized. Further details relating to this type of disc drive interfacing are disclosed in commonly assigned co-pending U.S. Patent Application Serial No. 09/986,078 entitled “Interactive System For Analyzing Biological Samples And Processing Related Information And The Use Thereof " filed November 7, 2001 , which is incorporated herein by reference in its entirety.
  • the reflective disc 144 is shown with a cap 146, a channel layer 148, and a substrate 150.
  • the channel layer 148 may be formed by a thin-film adhesive member.
  • Cap 146 has inlet ports 152 for receiving samples and vent ports 154.
  • Cap 146 may be formed primarily from polycarbonate, and may be coated with a cap reflective layer 156 on the bottom thereof. Reflective layer 156 is preferably made from a metal such as aluminum or gold.
  • Channel layer 148 defines fluidic circuits 158 by having desired shapes cut out from channel layer 148.
  • Each fluidic circuit 158 preferably has a flow channel 160 and a return channel 162, and some have a mixing chamber 164.
  • a mixing chamber 166 can be symmetrically formed relative to the flow channel 160, while an off-set mixing chamber 168 is formed to one side of the flow channel 160.
  • Fluidic circuits 158 are rather simple in construction, but a fluidic circuit can include other channels and chambers, such as preparatory regions or a waste region, as shown, for example, in U.S. Patent No. 6,030,581 entitled "Laboratory in a Disk" which is incorporated herein by reference.
  • Fluidic circuits can include valves and other fluid control structures such as those alternatively employed herein and discussed in further detail in connection with Figs. 33A-33D, 34A-34C, 35, and 36A-36C.
  • Channel layer 148 can include adhesives for bonding to the substrate and to the cap.
  • Substrate 150 has a plastic layer 172, and has target zones 170 formed as openings in a substrate reflective layer 174 deposited on the top of layer 172.
  • reflective layer 174 is used to encode operational information.
  • Plastic layer 172 is preferably formed from polycarbonate.
  • Target zones 170 may be formed by removing portions of the substrate reflective layer 174 in any desired shape, or by masking target zone areas before applying substrate reflective layer 174.
  • the substrate reflective layer 174 is preferably formed from a metal, such as aluminum or gold, and can be configured with the rest of the substrate to encode operational information that is read with incident light, such as through a wobble groove or through an arrangement of pits.
  • Target zones are where investigational features are detected. If the target zone is a location where an antibody, strand of DNA, or other material that can bind to a target is located, the target zone can be referred to as a capture zone.
  • optical disc 144 is cut away to illustrate a partial cross-sectional perspective view.
  • An active layer 176 is formed over substrate reflective layer 174.
  • Active layer 176 may generally be formed from nitrocellulose, polystyrene, polycarbonate, gold, activated glass, modified glass, or a modified polystyrene such as, for example, polystyrene-co-maleic anhydride.
  • channel layer 148 is situated over active layer 174.
  • samples can be introduced through inlet ports 152 of cap 146. When rotated, the sample moves outwardly from inlet port 152 along active layer 176.
  • detectable features referred to as investigational features
  • Examples of such processes are shown in the incorporated U.S. Patent No. 6,030,581 and in commonly assigned, co-pending U.S. Patent Application No. 09/988,728 entitled “Methods And Apparatus For Detecting And Quantifying Lymphocytes With Optical Biodiscs” filed November 16, 2001 ; and U.S. Patent Application No.
  • the investigational features captured within the target zones, by the capture layer with a capture agent may be designed to be located in the focal plane coplanar with reflective layer 174, where an incident beam is typically focused in conventional readers. Alternatively, the investigational features may be captured in a plane spaced away from the focal plane.
  • the former configuration is referred to as a "proximal” type disc, and the latter a “distal” type disc.
  • the transmissive optical disc 180 includes a clear cap 182, a channel layer 148, and a substrate 150.
  • the clear cap 182 includes inlet ports 152 and vent ports 154 and is preferably formed mainly from polycarbonate.
  • Trigger marks 184 may be included on the cap 182.
  • Channel layer 148 has fluidic circuits 158, which can have structure and use similar to those described in conjunction with Figs. 3A, 3B, and 3C.
  • Substrate 150 may include target zones 170, and preferably includes a polycarbonate layer 172.
  • Substrate 150 may, but need not, have a thin semi- reflective layer 186 deposited on top of layer 172.
  • Semi-reflective layer 186 is preferably significantly thinner than substrate reflective layer 174 on substrate 150 of reflective disc 144 (Figs. 3A-3C).
  • Semi-reflective layer 186 is preferably formed from a metal, such as aluminum or gold, but is sufficiently thin to allow a portion of an incident light beam to penetrate and pass through layer 186, while some of the incident light is reflected back.
  • a gold film layer for example, is 95% reflective at a thickness greater than about 700 ⁇ , while the transmission of light through the gold film is about 50% transmissive at approximately 100 A.
  • Fig. 4C is a cut-away perspective view of transmissive disc 180.
  • the semi- reflective nature of layer 186 makes its entire surface potentially available for target zones, including virtual zones defined by trigger marks or encoded data patterns on the disc.
  • Target zones 170 may also be formed by marking the designated area in the indicated shape or alternatively in any desired shape. Markings to indicate target zone 170 may be made on semi-reflective layer 186 or on a bottom portion of substrate 150 (under the disc). Target zones 170 may be created by silk screening ink onto semi-reflective layer 186.
  • An active layer 176 is applied over semi-reflective layer 186.
  • Active layer 176 may be formed from the same materials as described above in conjunction with layer 176 (Fig. 3C) and serves substantially the same purpose when a sample is provided through an opening in disc 180 and the disc is rotated.
  • transmissive disc 180 there is no reflective layer, on the clear cap 182, comparable to reflective layer 156 in reflective disc 144 (Fig. 3C).
  • FIG. 5A there is shown a cross sectional view taken across the tracks of the reflective disc embodiment 144 (Figs. 3A-3C) of the bio-disc 110 (Fig. 1) according to the present invention. As illustrated, this view is taken longitudinally along a radius and flow channel of the disc.
  • Fig. 5A includes the substrate 150 which is composed of a plastic layer 172 and a substrate reflective layer 174.
  • the substrate 150 includes a series of grooves 188.
  • the grooves 188 are in the form of a spiral extending from near the center of the disc toward the outer edge.
  • the grooves 188 are implemented so that the interrogation or incident beam 122 may track along the spiral grooves 188 on the disc.
  • This type of groove 188 is known as a "wobble groove".
  • the groove 188 is formed by a bottom portion having undulating or wavy side walls. A raised or elevated portion separates adjacent grooves 188 in the spiral.
  • the reflective layer 174 applied over the grooves 188 in this embodiment is, as illustrated, conformal in nature.
  • Fig. 5A also shows the active layer 176 applied over the reflective layer 1 4.
  • the target zone 170 is formed by removing an area or portion of the reflective layer 174 at a desired location or, alternatively, by masking the desired area prior to applying the reflective layer 174.
  • the plastic adhesive member or channel layer 148 is applied over the active layer 176.
  • Fig. 5A also shows the cap portion 146 and the reflective surface 156 associated therewith. Thus, when the cap portion 146 is applied to the plastic adhesive member 148 including the desired cutout shapes, the flow channel 160 is thereby formed.
  • Fig. 5B is a cross sectional view, similar to that illustrated in Fig. 5A, taken across the tracks of the transmissive disc embodiment 180 (Figs. 4A-4C) of the bio- disc 110 (Fig. 1) according to the present invention. This view is taken longitudinally along a radius and flow channel of the disc.
  • Fig. 5B illustrates the substrate 150 that includes the thin semi-reflective layer 186. This thin semi-reflective layer 186 allows the incident or interrogation beam 122, from the light source 118 (Fig. 2), to penetrate and pass through the disc to be detected by the top detector 130, while some of the light is reflected back in the form of the return beam 124.
  • the thickness of the thin semi-reflective layer 186 is determined by the minimum amount of reflected light required by the disc reader to maintain its tracking ability.
  • the substrate 150 in this embodiment like that discussed in Fig. 5A, includes the series of grooves 188.
  • the grooves 188 in this embodiment are also preferably in the form of a spiral extending from near the center of the disc toward the outer edge.
  • the grooves 188 are implemented so that the interrogation beam 122 may track along the spiral.
  • Fig. 5B also shows the active layer 176 applied over the thin semi- reflective layer 186.
  • the plastic adhesive member or channel layer 148 is applied over the active layer 176.
  • Fig. 5B also shows the clear cap 182.
  • Fig. 6A is a view similar to Fig. 5A but taken perpendicularly to a radius of the disc to illustrate the reflective disc and the initial refractive property thereof when observing the flow channel 160 from a radial perspective.
  • Fig. 6B is a similar view to Fig.
  • Figs. 5A, 5B, 6A, and 6B show the entire thickness of the respective reflective and transmissive discs.
  • the incident beam 122 is illustrated initially interacting with the substrate 150 which has refractive properties that change the path of the incident beam as shown to provide focusing of the beam 122 on the reflective layer 174 or the thin semi-reflective layer 186.
  • Capture bead 190 can be used in conjunction with a variety of different assays including biological assays such as immunoassays (Figs. 7B-10B), molecular assays, and more specifically genetic assays (Figs. 7A-10A).
  • biological assays such as immunoassays (Figs. 7B-10B), molecular assays, and more specifically genetic assays (Figs. 7A-10A).
  • antibody transport probes 196 are conjugated onto the beads.
  • Antibody transport probes 196 include proteins, such as antigens or antibodies, implemented to capture protein targets.
  • oligonucleotide transport probes 198 would be conjugated onto the beads.
  • Oligonucleotide transport probes 198 include nucleic acids such as DNA or RNA implemented to capture genetic targets.
  • a target agent such as target DNA or RNA 202, obtained from a test sample, is added to a capture bead 190 coated with oligonucleotide transport probes 198.
  • transport probes 198 are formed from desired sequences of nucleic acids. Aspects relating to DNA probe conjugation onto solid phase of this system of assays are discussed in further detail in commonly assigned and co-pending U.S. Provisional Application Serial No. 60/278,685 entitled "Use of Double Stranded DNA for Attachment to Solid Phase to Reduce Non- Covalent Binding" filed March 26, 2001. This application is herein incorporated by reference in its entirety.
  • a target agent such as target antigen 204 from a test sample is added to a capture bead 190 coated with antibody transport probes 196.
  • the transport probes 196 are formed from proteins such as antibodies.
  • Capture bead 190 has a characteristic that allows it to be isolated from a material suspension or solution.
  • the capture bead may be selected based upon a desired size, and a preferred way to make it isolatable is for it to be magnetic.
  • Fig. 8A illustrates the binding of target DNA or RNA 202 to complementary transport probes 198 on capture bead 190 in the genetic assay implementation of the present invention.
  • Fig. 8B shows an immunoassay version of Fig. 8A, transport probes 196 can alternatively include antibodies or antigens for binding to a target protein 204.
  • Fig. 9A shows a reporter bead 192 coated with oligonucleotide signal probes
  • Reporter bead 192 is selected based upon a desired size and the material properties for detection and reporting purposes. In one specific embodiment a 2.1 micron polystyrene bead is employed.
  • Signal probes 206 can be strands of DNA or RNA to capture target DNA or RNA.
  • Fig. 9B illustrates a reporter bead 192 coated with antibody signal probes 208 that bind to the target agent 204 as shown in Fig. 8B.
  • Reporter bead 192 is selected based upon a desired size and the material properties for detection and reporting purposes. This may also preferably include a 2.1 micron polystyrene bead.
  • Signal probes 208 can be antigens or antibodies implemented to capture protein or glycoportein targets.
  • Fig. 10A is a pictorial representation of a dual bead complex 194 that can be formed from capture bead 190 with probe 198, target agent 202, and reporter bead 192 with probe 206.
  • Probes 198 and 206 conjugated on capture bead 190 and reporter bead 192, respectively, have sequences complementary to the target agent 202, but not to each other. Further details regarding target agent detection and methods of reducing non-specific binding of target agents to beads are discussed in commonly assigned and co-pending U.S. Provisional Application Serial No. 60/278,106 entitled “Dual Bead Assays Including Use of Restriction Enzymes to Reduce Non-Specific Binding" filed March 23, 2001 ; and U.S. Provisional Application Serial No. 60/278,110 entitled “Dual Bead Assays Including Use of Chemical Methods to Reduce Non-Specific Binding” also filed March 23, 2001 , which are both incorporated herein by reference in their entirety.
  • Fig. 10B is a pictorial representation of the immunoassay version of a dual bead complex 194 that can be formed from capture bead 190 with probe 196, target agent 204, and reporter bead 192 with probe 208.
  • the efficiency and specificity of target agent binding may be enhanced by using a cleavable spacer that temporarily links the reporter bead 192 and capture bead 190.
  • the dual bead complex formed by the cleavable spacer essentially places the transport probe and the signal probe in close proximity to each other thus allowing more efficient target binding to both probes.
  • the spacer may then be cleaved permitting the bound target agent to retain the dual bead structure.
  • Fig. 11 A there is illustrated a method of preparing a molecular assay using a "single-step hybridization" technique to create dual bead complex structures in a solution according to one aspect of the present invention.
  • This method includes 5 principal steps identified consecutively as Steps I, II, III, IV, and V.
  • Step I of this method a number of capture beads 190 coated with oligonucleotide transport probes 198 are deposited into a test tube 212 containing a buffer solution 210.
  • the number of capture beads 190 used in this method may be, for example, on the order of 10E+07 and each on the order of 1 micron or greater in diameter.
  • Capture beads 190 are suspended in hybridization solution and are loaded into the test tube 212 by injection with pipette 214.
  • the preferred hybridization solution is composed of 0.2M NaCI, 10mM MgCl2, 1 mM EDTA, 50mM Tris-HCI, pH 7.5, and 5X Denhart's mix.
  • a desirable hybridization temperature is 37 degrees Celsius.
  • transport probes 198 are conjugated to 3 micron magnetic capture beads 190 by EDC conjugation. Further details regarding conjugation methods are disclosed in commonly assigned U.S. Provisional Application Serial No. 60/271 ,922 entitled, “Methods for Attaching Capture DNA and Reporter DNA to Solid Phase Including Selection of Bead Types as Solid Phase” filed February 27, 2001 ; and U.S. Provisional Application Serial No. 60/277,854 entitled “Methods of Conjugation for Attaching Capture DNA and Reporter DNA to Solid Phase” filed March 22, 2001 , both of which are herein incorporated by reference in their entirety. As shown in Step II, target DNA or RNA 202 is added to the solution.
  • Oligonucleotide transport probes 198 are complementary to the DNA or RNA target agent 202.
  • the target DNA or RNA 202 thus binds to the complementary sequences of transport probe 198 attached to the capture bead 190 as shown in Fig. 8A.
  • reporter beads 192 coated with oligonucleotide signal probes 206 are complementary to the target DNA or RNA 202.
  • signal probes 206 which are complementary to a portion of the target DNA or RNA 202, are conjugated to 2.1 micron fluorescent reporter beads 192.
  • Signal probes 206 and transport probes 198 each have sequences that are complementary to the target DNA 202, but not complementary to each other.
  • the dual bead complex 194 is formed such that the target DNA 202 links capture bead 190 and reporter beads 192. With specific and thorough washing, there should be minimal non-specific binding between reporter bead 192 and capture bead 190.
  • the target agent 202 and signal probe 206 are preferably allowed to hybridize for three to four hours at 37 degrees Celsius.
  • the disc drive motor 140 and controller 142, Fig. 2 may be advantageously employed to periodically rotate the disc to achieve the desired intermittent mixing.
  • This may be implemented in mixing protocols encoded on the disc that rotate the disc in one direction, then stop the disc, and thereafter rotate the disc again in the same direction in a prescribed manner with a preferred duty cycle of rotation and stop sessions.
  • the encoded mixing protocol may rotate the disc in a first direction, then stop the disc, and thereafter rotate the disc again in the opposite direction with a preferred duty cycle of rotation, stop, and reverse rotation sessions.
  • the dual bead complex 194 is separated from unbound reporter beads in the solution.
  • the solution can be exposed to a magnetic field to capture the dual bead complex structures 194 using the magnetic properties of capture bead 190.
  • the magnetic field can be encapsulated in a magnetic test tube rack 216 with a built-in magnet 218, which can be permanent or electromagnetic to draw out the magnetic beads and remove any unbound reporter beads in the suspension. Note that capture beads not bound to reporter beads will also be isolated. Alternatively, this magnetic removal step may be performed on-disc as shown in Figs. 33A, 35, and 36A-36C.
  • the purification process illustrated in Step IV includes the removal of supernatant containing free-floating particles.
  • Wash buffer is added into the test tube and the bead solution is mixed well.
  • the preferred wash buffer for the one step assay consists of 145mM NaCI, 50mM Tris, pH 7.5, 0.1 % SDS, 0.05% Tween, 0.25% NFDM, and 10mM EDTA.
  • Most of the unbound reporter beads 182, free- floating DNA, and non-specifically bound particles are agitated and removed from the supernatant.
  • the dual bead complex can form a matrix of capture beads, target sequences, and reporter beads, wherein the wash process can further assist in the extraction of free floating particles trapped in the lattice structure of overlapping dual bead particles.
  • Step V The last principal step shown in Fig. 1 1 A is Step V.
  • the assay mixture may be loaded into the disc and ready to be analyzed.
  • Fig. 1 1 B illustrates an immunoassay using a "single-step antigen binding" method, similar to that in Fig. 11 A, to create dual bead complex structures in a solution.
  • This method similarly includes 5 principal steps. These steps are respectively identified as Steps I, II, III, IV, and V in Fig. 1 1 A.
  • capture beads 190 e.g., on the order of 10E+07 in number and each on the order of 1 micron or above in diameter, which are coated with antibody transport probes 196 are added to a buffer solution 210.
  • This solution may be that same as that employed in the method shown in Fig. 1 1 A or alternatively may be specifically prepared for use with immunochemical assays.
  • the antibody transport probes 196 have a specific affinity for the target antigen 204.
  • the transport probes 196 bind specifically to epitopes within the target antigen 204 as also shown in Fig. 8B.
  • antibody transport probes 196 that have an affinity for a portion of the target antigen may be conjugated to 3 micron magnetic capture beads 190 via EDC conjugation.
  • conjugation of the transport probes 196 to the capture bead 190 may be achieved by passive adsorption.
  • the target antigen 204 is added to the solution.
  • the target antigen 204 binds to the antibody transport probe 196 attached to the capture bead 190 as also shown in Fig. 8B.
  • reporter beads 192 coated with antibody signal probes 208 are added to the solution.
  • Antibody signal probes 208 specifically binds to the epitopes on target antigen 204 as also represented in Figs. 9B and 10B.
  • signal probes 208 are conjugated to 2.1 micron fluorescent reporter beads 192.
  • Signal probes 208 and transport probes 196 each bind to specific epitopes on the target antigen, but not to each other.
  • the dual bead complex 194 is formed such that the target antigen 204 links capture bead 190 and reporter bead 192. With specific and thorough washing, there should be minimal non-specific binding between reporter bead 192 and capture bead 190.
  • Step IV after the binding in Step III, the dual bead complex 194 is separated from unbound reporter beads in the solution.
  • the solution can be exposed to a magnetic field to capture the dual bead complex structures 194 using the magnetic properties of capture bead 190.
  • the magnetic field can be encapsulated in a magnetic test tube rack 216 with a built-in magnet 218, which can be permanent or electromagnetic to draw out the magnetic beads and remove any unbound reporter beads in the suspension. Note that capture beads not bound to reporter beads will also be isolated. Alternatively, as indicated above, this magnetic removal step may also be performed on-disc as shown in Figs. 33A, 35, and 36A- 36C.
  • the purification process of Step IV includes the removal of supernatant containing free-floating particles. Wash buffer is added into the test tube and the bead solution is mixed well. Most of the unbound reporter beads 182, free-floating protein samples, and non-specifically bound particles are agitated and removed from the supernatant.
  • the dual bead complex can form a matrix of capture beads, target antigen, and reporter beads, wherein the wash process can further assist in the extraction of free floating particles trapped in the lattice structure of overlapping dual bead particles.
  • Fig. 12A shows an alternative genetic assay method referred to here as a "two-step hybridization" to create the dual bead complex which has 6 principal steps.
  • capture beads are coated with oligonucleotide transport probes 198 complementary to DNA or RNA target agent and placed into a buffer solution.
  • transport probes that are complementary to a portion of target agent are conjugated to 3 micron magnetic capture beads via EDC conjugation.
  • capture beads 190 suspended in hybridization solution, are loaded from the pipette 214 into the test tube 212.
  • the preferred hybridization solution is composed of 0.2M NaCI, 10mM MgCI 2 , 1 mM EDTA, 50mM Tris-HCI, pH 7.5, and 5X Denhart's mix.
  • a desirable hybridization temperature is 37 degrees Celsius.
  • target DNA or RNA 202 is added to the solution and binds to the complementary sequences of transport probe 198 attached to capture bead 190.
  • target agent 202 and the transport probe 198 are allowed to hybridize for 2 to 3 hours at 37 degrees Celsius. Sufficient hybridization, however, may be achieved within 30 minutes at room temperature. At higher temperatures, hybridization may be achieved substantially instantaneously.
  • target agents 202 bound to the capture beads are separated from unbound species in solution by exposing the solution to a magnetic field to isolate bound target sequences by using the magnetic properties of the capture bead 190.
  • the magnetic field can be enclosed in a magnetic test tube rack 216 with a built-in magnet permanent 218 or electromagnet to draw out the magnetic beads and remove any unbound target DNA 202 free-floating in the suspension via pipette extraction of the solution.
  • this magnetic removal step may be performed as shown in Figs. 33A, 35, and 36A-36C.
  • a wash buffer is added and the separation process can be repeated.
  • the preferred wash buffer after the transport probes 198 and target DNA 202 hybridize consists of 145mM NaCI, 50mM Tris, pH 7.5, and 0.05% Tween.
  • Hybridization methods and techniques for decreasing non-specific binding of target agents to beads are further disclosed in commonly assigned and co-pending U.S. Provisional Application Serial No. 60/278,691 entitled "Reduction of Non-Specific Binding of Dual Bead Assays by Use of Blocking Agents" filed March 26, 2001. This application is herein incorporated by reference in its entirety.
  • reporter beads 192 are added to the solution as discussed in conjunction with the method shown in Fig. 1 1 A.
  • Reporter beads 192 are coated with signal probes 206 that are complementary to target agent 202.
  • signal probes 206 which are complementary to a portion of target agent 202, are conjugated to 2.1 micron fluorescent reporter beads 192.
  • Signal probes 206 and transport probes 198 each have sequences that are complementary to target agent 202, but not complementary to each other.
  • the dual bead complex structures 190 are formed. As would be readily apparent to one of skill in the art, the dual bead complex structures are formed only if the target agent of interest is present.
  • target agent 202 links magnetic capture bead 190 and reporter bead 192.
  • Target agent 202 and signal probe 206 are preferably allowed to hybridize for 2-3 hours at 37 degrees Celsius. As with Step II discussed above, sufficient hybridization may be achieved within 30 minutes at room temperature. At higher temperatures, the hybridization in this step may also be achieved substantially instantaneously.
  • Step V shown in Fig. 12A after the hybridization in Step IV, the dual bead complex 194 is separated from unbound species in solution.
  • the solution is again exposed to a magnetic field to isolate the dual bead complex 194 using the magnetic properties of the capture bead 190.
  • the isolate will include capture beads not bound to reporter beads.
  • this magnetic separation step may be performed as shown in Figs. 33A, 35, and 36A-36C.
  • a purification process to remove supernatant containing free-floating particles includes adding wash buffer into the test tube and mixing the bead solution well.
  • the preferred wash buffer for the two-step assay consists of 145mM NaCI, 50mM Tris, pH 7.5, 0.1 % SDS, 0.05% Tween, 0.25% NFDM, and 10mM EDTA. Most unbound reporter beads, free-floating DNA, and non-specifically bound particles are agitated and removed from the supernatant.
  • the dual bead complex can form a matrix of capture beads, target agents, and reporter beads, wherein the wash process can further assist in the extraction of free floating particles trapped in the lattice structure of overlapping dual bead particles.
  • Step VI The final principal step shown in Fig. 12A is Step VI.
  • the assay mixture is loaded into the disc and analyzed.
  • the oligonucleotide signal and transport probes may be ligated to prevent breakdown of the dual bead complex during the disc analysis and signal detection processes. Further details regarding probe ligation methods are disclosed in commonly assigned and co-pending U.S. Provisional Application Serial No. 60/278,694 entitled "Improved Dual Bead Assays Using Ligation" filed March 26, 2001 , which is herein incorporated in its entirety by reference.
  • Fig. 12B shows an immunoassay method, similar to those discussed in connection with the immunoassay method of Fig. 1 1 B and following the steps of the genetic assay of Fig. 12A.
  • This method is also referred to here as a "two-step binding" to create the dual bead complex in an immunochemical assay.
  • this method includes 6 main steps.
  • capture beads coated with antibody transport probes that specifically bind to epitopes on target antigens are placed into a buffer solution.
  • antibody transport probes are conjugated to 3 micron magnetic capture beads. Different sized magnetic capture beads may be employed depending on the type of disc drive and disc assembly utilized to perform the assay.
  • Steps I, II, III, IV, V and VI are respectively identified as Steps I, II, III, IV, V and VI in Fig. 12B.
  • Step I With specific reference now to Step I shown in Fig. 12B, capture beads 190, suspended in buffer solution 210, are loaded into a test tube 212 via injection from pipette 214.
  • target antigen 204 is added to the solution and binds to the antibody transport probe 196 attached to capture bead 190.
  • Target antigen 204 and the transport probe 196 are preferably allowed to bind for 2 to 3 hours at 37 degrees Celsius. Shorter binding times are also possible.
  • target antigen 204 bound to the capture beads 190 is separated from unbound species in solution by exposing the solution to a magnetic field to isolate bound target proteins or glycoproteins by using the magnetic properties of capture bead 190.
  • the magnetic field can be enclosed in a magnetic test tube rack 216 with a built-in magnet permanent 218 or electromagnet to draw out the magnetic beads and remove any unbound target antigen 204 free-floating in the suspension via pipette extraction of the solution.
  • a wash buffer is added and the separation process can be repeated.
  • reporter beads 192 are added to the solution as discussed in conjunction with the method shown in Fig. 11 B.
  • Reporter beads 192 are coated with signal probes 208 that have an affinity for the target antigen 204.
  • signal probes 208 which bind specifically to a portion of target agent 204, are conjugated to 2.1 micron fluorescent reporter beads 192.
  • Signal probes 208 and transport probes 196 each bind to specific epitopes on the target agent 204, but do not bind to each other.
  • the dual bead complex structures 190 are formed.
  • target antigen 204 links magnetic capture bead 190 and reporter bead 192.
  • target antigen 204 and signal probe 208 are allowed to hybridize for 2-3 hours at 37 degrees Celsius. As with Step II discussed above, sufficient binding may be achieved within 30 minutes at room temperature. In the case of immunoassays temperatures higher than 37 degrees Celsius are not preferred because the proteins will denature.
  • Step V after the binding shown in Step IV, the dual bead complex 194 is separated from unbound species in solution. This is achieved by exposing the solution to a magnetic field to isolate the dual bead complex 194 using the magnetic properties of the capture bead 190 as shown. Note again that the isolate will include capture beads not bound to reporter beads.
  • a purification process to remove supernatant containing free-floating particles includes adding wash buffer into the test tube and mixing the bead solution well. Most unbound reporter beads, free-floating proteins, and non-specifically bound particles are agitated and removed from the supernatant.
  • the dual bead complex can form a matrix of capture beads, target agents, and reporter beads, wherein the wash process can further assist in the extraction of free floating particles trapped in the lattice structure of overlapping dual bead particles.
  • Step VI The final main step shown in Fig. 12B is Step VI. In this step, once the dual bead complex 194 has been washed approximately 3-5 times with wash buffer solution, the assay mixture is loaded into the disc and analyzed.
  • the magnetic removal or separation steps in the method shown in Fig. 12B may be alternatively performed on- disc using the disc, fluidic circuits, and apparatus illustrated in Figs. 33A-33D, 34A- 34C, 35, and 36A-36C.
  • FIG. 13 there is shown a cross sectional view illustrating the disk layers (similar to Fig. 6) of the mixing or loading chamber 164. Access to the loading chamber 164 is achieved by an inlet port 152 where the dual bead assay preparation is loaded into the disc system.
  • Fig. 14 is a view similar to Fig. 13 showing the mixing or loading chamber 164 with the pipette 214 injection of the dual bead complex 194 onto the disc.
  • the complex includes reporters 192 and capture bead 190 linked together by the target DNA or RNA 202.
  • the signal DNA 206 is illustrated as single stranded DNA complementary to the capture agent.
  • the discs illustrated in Figs. 13 and 14 may be readily adapted to other assays including the immunoassays and general molecular assays discussed above which employ, alternatively, proteins such as antigens or antibodies implemented as the transport probes, target agents, and signal probes accordingly.
  • Fig. 15A shows the flow channel 160 and the target or capture zone 170 after anchoring of dual bead complex 194 to a capture agent 220.
  • the capture agent 220 in this embodiment is attached to the active layer 176 by applying a small volume of capture agent solution to the active layer 176 to form clusters of capture agents within the area of the target zone 170.
  • the capture agent includes biotin or BSA-biotin.
  • Fig. 15A also shows reporters 192 and capture beads 190 as components of a dual bead complex 194 as employed in the present invention.
  • anchor agents 222 are attached to the reporter beads 192.
  • the anchor agent 222 in this embodiment, may include streptavidin or Neutravidin.
  • an interrogation beam 224 directed to the target zone 170 can be used to detect the dual bead complex 194 within the target zone 170.
  • Figs. 15A and 15B may alternatively be implemented on the transmissive disc shown in Figs. 4A-4C, 5B, and 6B.
  • Fig. 15B is a cross sectional view similar to Fig. 15A illustrating the entrapment of the reporter bead 192 within the target zone 170 after a subsequent change in disc rotational speed.
  • the change in rotational speed removes the capture beads 190 from the dual bead complex 194, ultimately isolating the reporter bead 192 in the target zone 170 to be detected by the interrogation or read beam 224.
  • Fig. 16A is a cross sectional view, similar to Fig. 15A, that illustrates an alternative embodiment to Fig. 15A wherein the signal probes 206 or anchor agents 222, on the reporter beads 192, directly hybridize to the capture agent 220.
  • Fig. 16A shows the flow channel 160 and the target or capture zone 170 after anchoring of dual bead complex 194 with the capture agent 220.
  • the capture agent 220 in this embodiment is attached to the active layer 176 by applying a small volume of capture agent solution to the active layer 176 to form clusters of capture agents within the area of the target zone 170.
  • the capture agent 220 may be attached to the active layer using an amino group that covalently binds to the active layer 176.
  • the capture agent includes DNA.
  • Fig. 16A also shows reporters 192 and capture beads 190 as components of a dual bead complex 194 as employed in the present invention.
  • anchor agents 222 are attached to the reporter beads 192.
  • the anchor agent 222 in this embodiment may be a specific sequence of nucleic acids that are complimentary to the capture agent 220 or the oligonucleotide signal probe 206 itself. So when the reporter beads 192 come in close proximity to the capture agents 220, hybridization occurs between the anchor agent 222 and the capture agent 220 thereby retaining the dual bead complex 194 within the target zone 170.
  • the signal probe 206 serves the function of anchor agent 222.
  • an interrogation beam 224 directed to the target zone 170 may be used to detect the dual bead complex 194 within the target zone 170.
  • Fig. 16B illustrates the embodiment in Fig. 16A after a subsequent change in disc rotational speed. The change in rational speed removes the capture bead 190 from the dual bead complex 194, ultimately isolating the reporter bead 192 and the target DNA sequence 202 in the target zone 170 to be detected by an interrogation beam 224.
  • Figs. 16A and 16B may alternatively be implemented on the transmissive disc illustrated in Figs. 4A-4C, 5B, and 6B.
  • anchor agents 222 are attached to the capture beads 190 instead of the reporter beads.
  • the anchor agent 222 in this embodiment may include streptavidin or Neutravidin.
  • the target zone 170 is coated with a capture agent 220.
  • the capture agent may include biotin or BSA-biotin.
  • Fig. 17 also shows reporters 192 and capture beads 190 as components of a dual bead complex 194 as employed in the present invention.
  • Fig. 18 is an alternative to the embodiment illustrated in Fig. 16A.
  • anchor agents 222 are attached to the capture beads 190 instead of the reporter beads.
  • the transport probes 198, or an anchor agent 222 on the capture bead 190 directly hybridizes to the capture agent 220.
  • the capture agent 220 includes specific sequences of nucleic acid.
  • the anchor agent 222 in this embodiment may be a specific sequence of nucleic acids that are complimentary to the capture agent 220 or the oligonucleotide signal transport probe 198 itself. So when the capture beads 190 come in close proximity to the capture agents 220, hybridization occurs between the anchor agent 222 and the capture agent 220 thereby retaining the dual bead complex 194 within the target zone 170.
  • an interrogation beam 224 directed to the target zone 170 can be used to detect the dual bead complex 194 within the target zone 170.
  • the embodiment of the present invention illustrated in Fig. 18, may alternatively be implemented on the transmissive disc shown in Figs. 4A-4C, 5B, and 6B.
  • Figs. 19A-19C are detailed partial cross sectional views showing the active layer 176 and the substrate 174 of the present bio-disc 110 as implemented in conjunction with the genetic assays discussed herein.
  • Figs. 19A-19C illustrates the capture agent 220 attached to the active layer 176 by applying a small volume of capture agent solution to the active layer 176 to form clusters of capture agents within the area of the target zone. The bond between capture agent 220 and the active layer 176 is sufficient so that the capture agent 220 remains attached to the active layer 176 within the target zone when the disc is rotated.
  • Figs. 19A and 19B also depict the capture bead 190 from the dual bead complex 194 binding to the capture agent 220 in the capture zone.
  • the capture agent 220 includes biotin and BSA-biotin.
  • the reporter bead 192 anchors the dual bead complex 194 in the target zone via biotin/streptavidin interactions.
  • the target zone may be coated with streptavidin and may bind biotinylated reporter beads.
  • Fig. 19C illustrates an alternative embodiment which includes an additional step to those discussed in connection with Figs. 19A and 19B.
  • a variance in the disc rotations per minute may create a centrifugal force great enough to break the capture beads 190 away from the dual bead complex 194 based on the differential size and/or mass of the bead.
  • the reporter bead 192 remains anchored to the target zone.
  • the reporter beads 192 are maintained within the target zone and detected using an optical bio- disc or medical CD reader.
  • connection Figs. 19A- 19C may be implemented on the reflective disc illustrated in Figs. 3A-3C, 5A, and 6A or on the transmissive disc shown in Figs. 4A-4C, 5B, and 6B.
  • Figs. 20A, 20B, and 20C illustrate an alternative embodiment to the embodiment discussed in Figs. 19A-19C.
  • Figs. 20A-20C show detailed partial cross sectional views of a target zone implemented in conjunction with immunochemical assays.
  • Figs. 20A and 20B also depict the capture bead 190 from the dual bead complex 194 binding to the capture agent 220 in the capture zone.
  • the capture agent 220 includes biotin and BSA-biotin. These dual bead complexes may be prepared according to methods such as those discussed in Figs. 11 B and 12B.
  • the reporter bead 192 anchors the dual bead complex 194 in the target zone via biotin/streptavidin interactions.
  • Figs. 20A-20C may be implemented on the reflective disc depicted in Figs. 3A-3C, 5A, and 6A or on the transmissive disc shown in Figs. 4A-4C, 5B, and 6B.
  • FIGs. 21A, 21 B, and 21 C there is shown detailed partial cross sectional views of a target zone including the active layer 176 and the substrate 174 of the present bio-disc 110 as implemented in conjunction with the genetic assays discussed herein.
  • Figs. 21A-21C illustrate the capture agent 220 attached to the active layer 176 by use of an amino group 226 that is an integral part of the capture agent 220. As indicated, the capture agent 220 is situated within the target zone. The bond between the amino group 226 and the capture agent 220, and the amino group 226 and the active layer 176 is sufficient so that the capture agent 220 remains attached to the active layer 176 within the target zone when the disc is rotated.
  • the preferred amino group 226 is NH 2 .
  • the capture agent 220 includes the specific sequences of amino acids that are complimentary to anchor agent 222 or oligonucleotide signal probe 206 which are attached to the reporter bead 192.
  • Fig. 21 B depicts the reporter bead 192 of the dual bead complex 194, prepared according to methods such as those discussed in Figs. 11A and 12A, binding to the capture agent 220 in the target zone.
  • the reporter bead 192 anchors the dual bead complex 192 within the target zone.
  • Fig. 21 C illustrates an alternative embodiment that includes an additional step to those discussed in connection with Figs. 21A-21 B.
  • a variance in the disc rotations per minute may create enough centrifugal force to break the capture beads 190 away from the dual bead complex 194 based on the differential size and/or mass of the bead.
  • the reporter bead 192 with the target DNA sequence 202 remains anchored to the target zone. In either case, the reporter beads 192 are maintained within the target zone as desired.
  • the embodiment of the present invention discussed with reference to Figs. 21A-21 C may be implemented on the reflective disc shown in Figs. 3A-3C, 5A, and 6A or on the transmissive disc illustrated in Figs. 4A-4C, 5B, and 6B.
  • Figs. 22A, 22B, and 22C illustrate an alternative embodiment to the embodiment discussed in Figs. 21A-21 C.
  • Figs. 22A-22C show detailed partial cross sectional views of a target zone implemented in conjunction with immunochemical assays.
  • Figs. 22A and 22B also depict the reporter bead 192 from the dual bead complex 194, prepared according to methods such as those discussed in Figs. 1 1 B and 12B, binding to the capture agent 220 in the capture zone.
  • the capture agent 220 includes antibodies bound to the target zone by use of an amino group 226 that is made an integral part of the capture agent 220.
  • the capture agents 220 may be bound to the active layer 176 by passive absorption, and hydrophobic or ionic interactions.
  • the reporter bead 192 anchors the dual bead complex 194 in the target zone via specific antibody binding.
  • Fig. 22C shows an alternative embodiment that includes an additional step to those discussed in connection with Figs. 22A-22B.
  • a variance in the disc rotations per minute may create enough centrifugal force to break the capture beads 190 away from the dual bead complex 194 based on the differential size and/or mass of the bead.
  • the reporter bead 192 with the target antigen 204 remains anchored to the target zone. In either case, the reporter beads 192 are maintained within the target zone as desired.
  • Figs. 22A-22C may be implemented on the reflective disc illustrated in Figs. 3A-3C, 5A, and 6A or on the transmissive disc shown in Figs. 4A-4C, 5B, and 6B.
  • Figs. 23A and 23B are detailed partial cross sectional views showing the active layer 176 and the substrate 174 of the present bio-disc 1 10 as implemented in conjunction with the genetic assays.
  • Figs. 23A and 23B illustrate an alternative embodiment to that discussed in Figs. 19A and 19B above.
  • the anchor agent 222 is attached to the capture bead 190 instead of the reporter bead 192.
  • Fig. 23B illustrates the capture bead 190, from the dual bead complex 194, binding to the capture agent 220 in the capture zone.
  • the capture agent 220 includes biotin and BSA-biotin.
  • the capture bead 190 anchors the dual bead complex 194 in the target zone via biotin/streptavidin interactions.
  • the embodiment of the present invention discussed with reference to Figs. 23A and 23B, may be implemented on the reflective disc illustrated in Figs. 3A-3C, 5A, and 6A or on the transmissive disc shown in Figs. 4A-4C, 5B, and 6B.
  • FIGs. 24A and 24B there is presented detailed partial cross sectional views showing the active layer 176 and the substrate 174 of the present bio-disc 110 as implemented in conjunction with the genetic assays.
  • Figs. 23A and 23B illustrate an alternative embodiment to that discussed in Figs. 21 A and 21 B above.
  • the anchor agent 222 is attached to the capture bead 190 instead of the reporter bead 192.
  • Fig. 23B illustrates the capture bead 190, from the dual bead complex 194, binding to the capture agent 220 in the capture zone.
  • the capture agent 220 is attached to the active layer 176 by use of an amino group 226 that is made an integral part of the capture agent 220. As indicated, the capture agent 220 is situated within the target zone. The bond between the amino group 226 and the capture agent 220, and the amino group 226 and the active layer 176 is sufficient so that the capture agent 220 remains attached to the active layer 176 within the target zone when the disc is rotated.
  • the capture agent 220 includes the specific sequences of amino acids that are complimentary to the anchor agent 222 or oligonucleotide transport probe 198 which are attached to the capture bead 190.
  • the capture bead 190 anchors the dual bead complex 194 in the target zone via hybridization between the capture agent 220 and the anchor agent or the transport probe 198.
  • Figs. 24A and 24B may be implemented on the reflective disc illustrated in Figs. 3A-3C, 5A, and 6A or on the transmissive disc depicted in Figs. 4A-4C, 5B, and 6B.
  • Figs. 25A-25D there is shown the target zones 170 set out in Figs. 21A-21 C and Figs. 24A-24B in the context of a disc, using as an input the solution created according to methods such as those shown in Figs. 11A and 12A.
  • Fig. 25A shows a mixing/loading chamber 164, accessible through an inlet port 152, and leading to a flow channel 160.
  • Flow channel 160 is pre-loaded with capture agents 220 situated in clusters.
  • Each of the clusters of capture agents 220 is situated within a respective target zone 170.
  • Each target zone 170 can have one type of capture agent or multiple types of capture agents, and separate target zones can have one and the same type of capture agent or multiple different capture agents in multiple capture fields.
  • the capture agent can include specific sequences of nucleic acids that are complimentary to anchor agents 222 on either the reporter 192 or capture bead 190.
  • a pipette 214 is loaded with a test sample of DNA or RNA that has been sequestered in the dual bead complex 194.
  • the dual bead complex is injected into the flow channel 160 through inlet port 152.
  • the dual bead complex 194 begins to move down flow channel 160 as the disc is rotated.
  • the loading chamber 164 can include a break-away retaining wall 228 so that complex 194 moves down the flow channel at one time.
  • anchor agents 222 attached to reporter beads 192, bind to the capture agents 220 by hybridization, as illustrated in Fig. 25C.
  • reporter beads 192 are retained within target zone 170. Binding can be further facilitated by rotating the disc so that the dual bead complex 194 can slowly move or tumble down the flow channel. Slow movement allows ample time for additional hybridization. After hybridization, the disc can be rotated further at the same speed or faster to clear target zone 170 of any unattached dual bead complex 194, as illustrated in Fig. 25D. An interrogation beam 224 can then be directed through target zones 170 to determine the presence of reporters, capture beads, and dual bead complex, as illustrated in Fig. 25D.
  • the speed, direction, and stages of rotation can all be encoded in the operational information on the disc.
  • the method discussed in connection with Figs. 25A-25D may also be performed on the transmissive disc illustrated in Figs. 4A-4C, 5B, and 6B using a system with the top detector 130.
  • Figs. 26A-26D show the target zones 170 including the capture chemistries discussed in Figs. 19A-19C and Figs. 23A-23B. This method uses as an input the solution created according to methods shown in Figs. 11 A and 12A. Figs. 26A-26D illustrate an alternative embodiment to that discussed in Figs. 25A-25D showing a different bead capture method described in further detail below.
  • Fig. 26A shows a mixing/loading chamber 164, accessible through an inlet port 152, and leading to a flow channel 160.
  • Flow channel 160 is pre-loaded with capture agents 220 situated in clusters.
  • Each of the clusters of capture agents 220 is situated within a respective target zone 170.
  • Each target zone 170 can have one type of capture agent or multiple types of capture agents, and separate target zones can have one and the same type of capture agent or multiple different capture agents in multiple capture fields.
  • the capture agent can include specific biotin and BSA-biotin that has affinity to the anchor agents 222 on either the reporter 192 or capture bead 190.
  • the anchor agents may include streptavidin and Neutravidin.
  • a pipette 214 is loaded with a test sample of DNA or RNA that has been sequestered in the dual bead complex 194.
  • the dual bead complex is injected into the flow channel 160 through inlet port 152.
  • the dual bead complex 194 begins to move down flow channel 160 as the disc is rotated.
  • the loading chamber 164 can include a break-away retaining wall 228 so that complex 194 moves down the flow channel at one time.
  • anchor agents 222 attached to reporter beads 192, bind to the capture agents 220 by biotin-streptavidin interactions, as illustrated in Fig. 26C.
  • reporter beads 192 are retained within target zone 170. Binding can be further facilitated by rotating the disc so that the dual bead complex 194 can slowly move or tumble down the flow channel. Slow movement allows ample time for additional binding between the capture agent 220 and the anchor agent 222. After binding, the disc can be rotated further at the same speed or faster to clear target zone 170 of any unattached dual bead complex 194, as illustrated in Fig. 26D.
  • An interrogation beam 224 can then be directed through target zones 170 to determine the presence of reporters, capture beads, and dual bead complex, as illustrated in Fig. 26D.
  • no target DNA is present in the test sample, there will be no dual bead complex structures beads bound to the target zones 170.
  • a small amount of background signal may be detected in the target zones from nonspecific binding.
  • the interrogation beam 224 is directed into the target zone 170, a zero or low reading results, thereby indicating that no target DNA or RNA was present in the sample.
  • the speed, direction, and stages of rotation such as one speed for one period followed by another speed for another period, can all be encoded in the operational information on the disc.
  • a reflective disc such as the disc shown in Figs. 3A-3C, 5A, and 6A. This method may also be performed on the transmissive disc shown in Figs. 4A-4C, 5B, and 6B using a system with the top detector 130.
  • FIGs. 27A-27D there is shown a series of cross sectional side views illustrating the steps of yet another alternative method according to the present invention.
  • Figs. 27A-27D show the target zones 170 including the capture mechanisms discussed in connection with Figs. 22A-22C. This method uses an input the solution created according to the preparation methods shown in Figs. 11 B and 12B.
  • Figs. 27A-27D illustrate an immunochemical assay and an alternative bead capture method.
  • Fig. 27A shows a mixing/loading chamber 164, accessible through an inlet port 152, and leading to a flow channel 160.
  • Flow channel 160 is pre-loaded with capture agents 220 situated in clusters.
  • Each of the clusters of capture agents 220 is situated within a respective target zone 170.
  • Each target zone 170 can have one type of capture agent or multiple types of capture agents, and separate target zones can have one and the same type of capture agent or multiple different capture agents in multiple capture fields.
  • the capture agent can include antibodies that specifically bind to epitopes on the anchor agents 222 on either the reporter 192 or capture bead 190.
  • the capture agent can directly bind to epitopes on the target antigen 204 within the dual bead complex 194.
  • the anchor agents 222 can include the target antigen, antibody transport probe 196, the antibody signal probe 208, or any antigen, bound to either the reporter bead 192 or the capture bead 190, that has epitopes than can specifically bind to the capture agent 220.
  • a pipette 214 is loaded with a test sample of target antigen that has been sequestered in the dual bead complex 194.
  • the dual bead complex is injected into the flow channel 160 through inlet port 152.
  • the dual bead complex 194 begins to move down flow channel 160 as the disc is rotated.
  • the loading chamber 164 may include a break-away retaining wall 228 so that complex 194 moves down the flow channel at one time.
  • anchor agents 222 attached to reporter beads 192, bind to the capture agents 220 by antibody-antigen interactions, as illustrated in Fig. 27C.
  • reporter beads 192 are retained within target zone 170. Binding can be further facilitated by rotating the disc so that the dual bead complex 194 can slowly move or tumble down the flow channel. Slow movement allows ample time for additional binding between the capture agents 220 and the anchor agent 222. After binding, the disc can be rotated further at the same speed or faster to clear target zone 170 of any unattached dual bead complex 194, as illustrated in Fig. 27D.
  • An interrogation beam 224 can then be directed through target zones 170 to determine the presence of reporters, capture beads, and dual bead complex, as illustrated in Fig. 27D.
  • no target antigen is present in the test sample, there will be no dual bead complex structures, reporters, or capture beads bound to the target zones 170, but a small amount of background signal may be detected in the target zones from non-specific binding.
  • the interrogation beam 224 is directed into the target zone 170, a zero or low reading results, thereby indicating that no target was present in the sample.
  • the speed, direction, and stages of rotation can all be encoded in the operational information on the disc.
  • the methods described in Figs. 25A-25D, 26A-26D, and 27A-27D are implemented using the reflective disc system 144. As indicated above, it should be understood that these methods and any other bead or sphere detection may also be carried out using the transmissive disc embodiment 180, as described in Figs. 4A- 4C, 5B, and 6B. It should also be understood that the methods described in Figs.
  • 11A-11 B, 12A-12B, 25A-25D, 26A-26D, and 27A-27D are not limited to creating the dual bead complexes outside of the optical bio-discs but may include embodiments that use "in-disc” or "on-disc” formation of the dual bead complexes.
  • the dual bead complex is formed within the fluidic circuits of the optical bio-disc 1 10.
  • the dual bead formation may be carried out in the loading or mixing chamber 164.
  • the beads and sample are added to the disc at the same time, or nearly the same time.
  • the beads with the probes can be pre-loaded on the disc for future use with a sample so that only a sample needs to be added.
  • the beads would typically have a long shelf life, with less shelf life for the probes.
  • the probes can be dried or lyophilized (freeze dried) to extend the period during which the probes can remain in the disc. With the probes dried, the sample essentially reconstitutes the probes and then mixes with the beads to produce dual bead complex structures can be performed.
  • the basic process for on-disc processing includes: (1) inserting the sample into a disc with beads with probes; (2) causing the sample and the beads to mix on the disc; (3) isolating, such as by applying a magnetic field, to hold the dual bead complex and move the non-held beads away, such as to a region referred to here as a waste chamber; and (4) directing the dual bead complexes (and any other material not moved to the waste chamber) to the capture fields.
  • the detection process can be the same as one of those described above, such as by event detection or fluorimetry.
  • the disc surface capturing techniques and the linking techniques for forming the dual bead complexes illustrated in Figs. 25A-25D, 26A-26D, and 27A-27D may be interchanged to create alternate variations thereof.
  • the capture agents 220 as implemented to include specific sequences of nucleic acids may be used to capture dual bead complexes formed by either DNA hybridization as illustrated in Fig. 10A or the antibody-antigen interactions shown in Fig. 10B.
  • capture agents 220 as implemented to include antibodies may be employed to capture dual bead complexes formed by either the DNA hybridization method shown in Fig. 10A or the antibody-antigen interactions illustrated in Fig.
  • capture agents 220 as implemented to include biotin or BSA-biotin may be similarly utilized to capture dual bead complexes formed by either the DNA hybridization techniques illustrated in Fig. 10A or the antibody- antigen interactions depicted in Fig. 10B.
  • Other combinations including different anchor agents to perform the binding function with the capture agent, are readily apparent from the present disclosure and are thus specifically provided for herein.
  • the number of reporter beads bound in the capture field can be detected in a qualitative manner, and may also be quantified by the optical disc reader.
  • test results of any of the test methods described above can be readily displayed on monitor 114 (Fig. 1).
  • the disc according to the present invention preferably includes encoded software that is read to control the controller, the processor, and the analyzer as shown in Fig. 2. This interactive software is implemented to facilitate the methods described herein and the display of results.
  • Fig. 28A is a graphical representation of an individual 2.1 micron reporter bead 192 and a 3 micron capture bead 190 positioned relative to tracks A, B, C, D, and E of an optical bio-disc or medical CD according to the present invention.
  • Fig. 28B is a series of signature traces, from tracks A, B, C, D, and E, derived from the beads of Fig. 28A utilizing a detected signal from the optical drive according to the present invention.
  • These graphs represent the detected return beam 124 of the reflective disc illustrated in Figs. 5A and 6A for example, or the transmitted beam 128 of the transmissive disc illustrated in Figs, 5B and 6B.
  • the signatures for a 2.1 micron reporter bead 190 are sufficiently different from those for a 3 micron capture bead 192 such that the two different types of beads can be detected and discriminated.
  • a sufficient deflection of the trace signal from the detected return beam as it passes through a bead is referred to as an event.
  • 29A is a graphical representation of a 2.1 micron reporter bead and a 3 micron capture bead linked together in a dual bead complex positioned relative to the tracks A, B, C, D, and E of an optical bio-disc or medical CD according to the present invention.
  • Fig. 29B is a series of signature traces, from tracks A, B, C, D, and E, derived from the beads of Fig. 29A utilizing a detected signal from the optical drive according to the present invention. These graphs represent the detected return beam 124 of a reflective disc 144 or transmitted beam 128 of a transmissive disc 180. As shown, the signatures for a 2.1 micron reporter bead 190 are sufficiently different from those for a 3 micron capture bead 192 such that the two different types of beads can be detected and discriminated. A sufficient deflection of the trace signal from the detected return beam or transmitted as it passes through a bead is referred to as an event. The relative proximity of the events from the reporter and capture bead indicates the presence or absence the dual bead complex. As shown, the traces for the reporter and the capture bead are right next to each other indicating the beads are joined in a dual bead complex.
  • reporter beads can be fluorescent or phosphorescent. Detection of these reporters can be carried out in fluorescent or phosphorescent type optical disc readers.
  • Other signal detection methods are described, for example, in commonly assigned co-pending U.S. Patent Application Serial No. 10/008,156 entitled “Disc Drive System and Methods for Use with Bio-Discs” filed November 9, 2001 , which is expressly incorporated by reference; U.S. Provisional Application Serial Nos. 60/270,095 filed February 20, 2001 and 60/292,108, filed May 18, 2001 ; and the above referenced U.S. Patent Application Serial No. 10/043,688 entitled "Optical Disc Analysis System Including Related Methods For Biological and Medical Imaging” filed January 10, 2002.
  • Fig. 30A is a bar graph of data generated using a fluorimeter showing concentration-dependent target detection using fluorescent reporter beads. This graph shows the molar concentration of target DNA versus the number of detected beads.
  • the dynamic range of target detection shown in the graph is 10E-16 to 10E- 10 Molar (moles/liter). While the particular graph shown was generated using data from a fluorimeter, the results may also be generated using a fluorescent type optical disc drive.
  • Fig. 30B presents a standard curve demonstrating that the sensitivity of a fluorimeter is approximately 1000 beads in a fluorescent dual bead assay.
  • the sensitivity of any assay depends on the assay itself and on the sensitivity of the detection system.
  • various studies were done to examine the sensitivity of the dual bead assay using different detection methods, e.g., a fluorimeter, and bio-disc or medical CD detection according to the present invention.
  • the sensitivity of a fluorimeter is approximately 1000 beads in a fluorescent dual bead assay.
  • Fig. 30B the sensitivity of a fluorimeter is approximately 1000 beads in a fluorescent dual bead assay.
  • a dual bead assay represents a very sensitive detection method for DNA that does not require DNA amplification (such as through PCR) and can be used to detect even a single bead.
  • a medical CD or bio- disc coupled with a CD-reader or optical bio-disc drive improves the sensitivity of detection.
  • detection with a fluorimeter is limited to approximately 1000 beads (Fig. 30B)
  • use of a bio-disc coupled with CD-reader may enable the user to detect a single bead with the interrogation beam as illustrated in Figs. 29A, 29B, and 30C.
  • the bioassay system provided herein improves the sensitivity of dual bead assays significantly.
  • Fig. 28B shows the signal traces of each bead as detected by the medical CD or bio-disc reader. Dual bead complexes may also be identified by the bio-disc reader using the unique signature traces collected from the detection of a dual bead complex as shown in Figs. 29A and 29B.
  • Different optical bio-disc platforms including but not limited to the reflective and the transmissive disc formats illustrated respectively in Figs. 3C and 4C, may be used in conjunction with the reader device for detection of beads.
  • Fig. 30C is a pictorial representation demonstrating the formation of the dual bead complex linked together by the presence of the target in a genetic assay. Sensitivity to within one reporter molecule is possible with the present dual bead assay quantified with a bio-CD reader shown in Figs. 1 and 2 above. Similarly, the dual bead complex formation may also be implemented in an immunochemical assay format as illustrated above in Figs. 7B, 8B, 9B, 10B, 11 B, and 12B.
  • Fig. 31 shows data generated using a fluorimeter illustrating the concentration-dependent detection of two different targets.
  • Target detection was carried out using two different methods (the single and the duplex assays).
  • the capture bead contains a transport probe specific to a single target and a reporter probe coated with a signal probe specific to the same target is mixed in a solution together with the target.
  • the capture bead contains two different transport probes specific to two different targets. Experimental details regarding the use of the duplex target detection method are discussed in further detail in Example 2. Mixing different reporter beads (red and green fluorescent or silica and polystyrene beads, for example) containing signal probes specific to one of the two targets, allows the detection of two different targets simultaneously.
  • Detection of the dual bead duplex assay may be carried out using a magneto- optical disc system described below.
  • Figs. 32 and 37 illustrate the formation and binding of various dual bead complexes onto an optical disc which may be detected by an optical bio-disc drive (Fig. 2), a magneto-optical disc system, a fluorescent disc system, or any similar device.
  • Unique signature traces of a dual bead complex collected from an optical disc reader are shown in Fig. 29B above. The traces from Fig. 29B further illustrate that different bead types can be detected by an optical disc reader since different beads show different signature profiles.
  • a dual bead assay in the capture of targets allows for the use in multiplexing assays.
  • This type of multiplexing is achieved by combining different sizes of magnetic beads with different types and sizes of reporter beads.
  • different target agents can be detected simultaneously.
  • four sizes of magnetic capture beads, and four sizes of three types of reporter beads produce up to 48 different types of dual bead complex.
  • probes specific to different targets are thus conjugated to capture beads.
  • 28A, 28B, 29A, and 29B small differences in size can be detected by detecting reflected or transmitted light.
  • Multiple dual bead complex structures for capturing different target agents can be carried out on or off the disc.
  • the dual bead suspension is loaded into a port on the disc.
  • the port is sealed and the disc is rotated in the disc reader.
  • free (unbound) beads are spun off to a periphery of the disc.
  • the reporter beads detecting various target agents are thus localized in capture fields. In this manner, the presence of a specific target agent can be detected, and the amount of a specific target agent can be quantified by the disc reader.
  • Fig. 33A is a general representation of an optical disc according to another aspect of the present invention and a method corresponding generally to the single- step method of Fig. 11 A and 1 1 B is shown.
  • the sample and beads can be added at one time or successively but closely in time. Alternatively, the beads can be preloaded into a portion of the disc.
  • These materials can be provided to a mixing chamber 164 that can have a breakaway wall 228 (see Fig. 25A), which holds in the solution within the mixing chamber 164. Mixing the sample and beads on the disc would be accomplished through rotation at a rate insufficient to cause the wall to break or the capillary forces to be overcome.
  • the disc can be rotated in one direction, or it can be rotated alternately in opposite directions to agitate the material in a mixing chamber.
  • the mixing chamber is preferably sufficiently large so that circulation and mixing is possible.
  • the mixing can be continuous or intermittent.
  • Fig. 33B shows one embodiment of a rotationally-directionally-dependent valve arrangement that uses a movable component for a valve.
  • the mixing chamber leads to an intermediate chamber 244 that has a movable component, such as a ball 246.
  • the ball 246 may be kept in a slight recessed portion, or chamber 244 may have a gradual V-shaped tapering in the circumferential direction to keep the ball centered when there is no rotation.
  • Figs. 33C and 33D in addition to Figs.
  • Figs. 34A-34C show a variation of the prior embodiment in which the ball is replaced by a wedge 252 that moves one way or the other in response to acceleration of the disc.
  • the wedge 252 can have a circular outer shape that conforms to the shape of an intermediate chamber 244.
  • the wedge is preferably made of a heavy dense material relative to chamber 244 to avoid sticking.
  • a coating can be used to promote sliding of the wedge relative to the chamber.
  • the angular acceleration causes wedge 252 to move to block a passage to detection chamber 234 and to allow flow to waste chamber 232.
  • the angular acceleration causes wedge 252 to block passage to waste chamber 232 and allows flow to detection chamber 234.
  • wedge 252 remains in place blocking the appropriate passage.
  • a magnetic field from a magnetic field generator or field coil 230 can be applied over the mixing chamber 164 to hold the dual bead complexes and unbound magnetic beads in place while material without magnetic beads are allowed to flow away to a waste chamber 232.
  • This technique may also be employed to aid in mixing of the assay solution within the fluidic circuits or channels before any unwanted material is washed away.
  • only magnetic capture beads, unbound or as part of a dual bead complex remain.
  • the magnetic field is released, and the dual bead complex with the magnetic beads is directed to a capture and detection chamber 234.
  • the process of directing non-magnetic beads to waste chamber 232 and then magnetic beads to capture chamber 234 can be accomplished through the microfluidic construction and/or fluidic components.
  • a flow control valve 236 or some other directing arrangement can be used to direct the sample and non-magnetic beads to waste chamber 232 and then to capture chamber 234.
  • a number of embodiments for rotationally dependent flow can be used.
  • Fig. 35 is a perspective view of a disc including one embodiment of a fluidic circuit employed in conjunction with magnetic beads and the magnetic field generator 230 according to the present invention. Fig. 35 also shows the mixing chamber 164, the waste chamber 232, and the capture chamber 234.
  • the magnetic field generator 230 is positioned over disc 110 and has a radius such that as disc 110 rotates, magnetic field generator 230 remains over mixing chamber 164, and is radially spaced from chambers 232 and 234.
  • a magnetic field from the magnetic field generator 230 can be applied over the mixing chamber 164 to hold the dual bead complexes and/or unbound magnetic beads in place while additional material is allowed to enter the mixing chamber 164.
  • the method of rotating the disc while holding magnetic beads in place with the magnetic field generator 230 may also be employed to aid in mixing of the assay solution within the mixing chamber 164 before the solution contained therein is directed elsewhere.
  • Figs. 36A-36C are plan views illustrating a method of separation and detection for dual bead assays using the fluidic circuit shown in Fig. 35.
  • Fig. 36A shows an unrotated optical disc with a mixing chamber 164 shaped as an annular sector holding a sample with dual bead complexes 194 and various unbound reporter beads 192.
  • the electromagnet is activated and the disc is rotated counter-clockwise (Fig. 36B), or it can be agitated at a lower rpm, such as 1X or 3X.
  • Dual bead complexes 194, with magnetic capture beads remain in mixing chamber 164 while the liquid sample and the unbound reporter beads 192 move in response to angular acceleration to a rotationally trailing end of mixing chamber 164.
  • the disc is rotated in the counter-clockwise direction illustrated in Fig. 36B with sufficient speed to overcome capillary forces to allow the unbound reporter beads in the sample to move through a waste fluidic circuit 238 to waste chamber 232.
  • the liquid will not move down the capture fluidic circuit 240 because of the physical configuration of the fluidic circuit as illustrated.
  • Fig. 36C the magnet is deactivated and the disc is rotated clockwise. Dual bead complexes 194 move to the opposite trailing end of the mixing chamber 164 in response to angular acceleration and then through a capture fluidic circuit 240 to the capture chamber 234. At this later stage in the process, the dual bead solution will not move down the waste fluidic circuit 238 due to the physical layout of the fluidic circuit, as shown.
  • the embodiment shown in Figs. 36A- 36C thus illustrates directionally-dependent flow as well as rotational speed dependent flow.
  • a plurality of regions can be formed and distributed about the disc, for example, in a regular manner to promote balance.
  • instructions for controlling the rotation can be provided on the disc. Accordingly, by reading the disc, the disc drive can have instructions to rotate for a particular period of time at a particular speed, stop for some period of time, and rotate in the opposite direction for another period of time.
  • the encoded information can include control instructions such as those relating to, for example, the power and wavelength of the light source. Controlling such system parameters is particularly relevant when fluorescence is used as a detection method.
  • a passage can have a material or configuration that can seal or dissolve either under influence from a laser in the disc drive, or with a catalyst pre-loaded in the disc, or such a catalyst provided in the test sample.
  • a gel may solidify in the presence of a material over time, in which case the time to close can be set sufficiently long to allow the unbound capture beads to flow to a waste chamber before the passage to the waste chamber closes.
  • the passage to the waste chamber can be open while the passage to the detection chamber is closed. After the unbound beads are directed to the waste chamber, the passage to the direction chamber is opened by energy introduced from the laser to allow flow to the detection chamber.
  • magneto-optic recording is an optical storage technique in which magnetic domains are written into a thin film by heating it with a focused laser in the presence of an external magnetic field. The presence of these domains is then detected by the same laser from differences in the polarization of the reflected light between the different magnetic domains in the layer (Kerr rotation). By switching either the magnetic field for constant high laser power, or modulating the laser power with a constant magnetic field, a data pattern can be written into the layer.
  • Many magneto-optic storage systems have been introduced into the market, including both computer data storage systems and audio systems (most notably MiniDisc).
  • a disc such as one used with a magneto-optical drive, has magnetic regions 242 that can be written and erased with a magnetic head.
  • this type of disc will generally be referred to as a "magneto-optical bio-disc” or an "MO bio-disc”.
  • a magneto-optical disc drive can create magnetic regions 242 as small as 1 micron by 1 micron square. The close-up section of the magnetic region 242 shows the direction of the magnetic field with respect to adjacent regions.
  • a magnetic bead array according to this aspect of the present invention, a set of three radially oriented magnetic capture regions 243 are shown, by way of example, with no beads attached to the magnetic capture regions in the columns illustrated therein.
  • Section A there is shown a set of four columns in Section A with individual magnetic beads magnetically attached to the magnetic areas in a magnetic capture region.
  • Another set of four columns arrayed in Section B is shown after binding of reporter beads to form dual bead complexes attached to specific magnetic areas, with different columns having different types of reporter beads.
  • some of the reporter beads utilized vary in size to thereby achieve the multiplexing aspects of the present invention as implemented on a magneto-optical bio-disc or MO medical disc.
  • Section C a single column of various dual bead complexes is shown as another example of multiplexing assays employing various bead sizes individually attached at separate magnetic areas.
  • the write head in an MO drive is employed to create magnetic areas, and then a sample can be directed over that area to capture magnetic beads provided in the sample. After introduction of the first sample set, other magnetic areas may also be created and another sample set can be provided to the newly created magnetic capture region for detection. Thus detection of multiple sample sets may be performed on a single disc at different time periods.
  • the magneto-optical drive also allows the demagnetization of the magnetic capture regions to thereby release and isolate the magnetic beads if desired.
  • this system provides for the controllable capture, detection, isolation, and release of one or more specific target molecules from a variety of different biochemical, chemical, or biological samples. As described above, a sample can be provided to a chamber on a disc.
  • a sample could be provided to multiple chambers that have sets of different beads.
  • a series of chambers can be created such that a sample can be moved by rotational motion from one chamber to the next, and separate tests can then be performed in each chamber.
  • MO bio-disc a large number of tests can be performed at one time and can be performed interactively. In this manner, when a test is performed and a result is obtained, the system can be instructed to create a new set of magnetic regions for capturing the dual bead complex. Regions can be created one at a time or in large groups, and can be performed in successive chambers that have different pre-loaded beads.
  • the "capture agent” is essentially the magnetic field created by the magnetic region on the disc and therefore there is no need to add an additional biological or chemical capture agent.
  • the MO bio-disc illustrated in Fig. 37 may include any of the fluidic circuits, mixing chambers, flow channels, detection chambers, inlet ports, or vent ports employed in the reflective and transmissive discs discussed above. Illustrative examples of the use of the MO bio-disc according to this aspect of the present are provided below in Examples 5 and 6. Genetic Assays using Ligation to Increase Assay Sensitivity
  • Fig. 38 there is shown the dual bead complex 194 held together by the target DNA 202 through the covalently bound transport probes 198 and signal probes 206 on the capture bead 190 and the reporter bead 192, respectively.
  • the 5' end of the signal probe 206 is held right next to the 3' end of the transport probe 198.
  • This configuration allows the ligation of the 3' and 5' ends of the probes upon addition of ligase. Ligation of both probes only occurs in the presence of the target and it enhances the sensitivity of the assay by increasing the bond strength between the reporter and capture beads preventing the dissociation of the dual bead complex.
  • Fig. 39 there is a bar graph illustrating the results from a genetic test detected by an enzyme assay.
  • a 3 ⁇ m capture bead bound to transport probes was used to capture the target in this test.
  • a biotinylated reporter probe was introduced and allowed to bind to the target.
  • the capture beads were then washed to remove unbound reporter probes.
  • Ligase is then added to the solution to ligate the ends of the reporter and transport probes, as shown in Fig. 38.
  • streptavidinated-alkaline phosphatase is added to the bead solution and allowed to bind with the biotin on the reporter probe.
  • the beads are again washed and a chromagen alkaline phosphatase substrate is added to the bead solution.
  • the intensity of the color formed by the alkaline phosphatase and substrate reaction is then quantified using a spectrophotometer. The results from this quantification are shown in Fig. 39.
  • the data presented in this figure indicates that there is approximately a 50% increase in signal when the probes are ligated. Thus the assay sensitivity is significantly increased by the ligation step in this experiment.
  • Examples 3 and 4 discuss in detail the procedures followed in carrying out a similar experiment.
  • Fig. 40 shows a bar graph from a genetic test using a ligation step implemented in a dual bead assay instead of an enzyme assay.
  • the enzyme assay as discussed in Fig. 39 is used to verify the activity of ligase in a non-dual bead format, which serves as a control in the dual bead experiment.
  • the same 3um capture beads bound to transport probes were used in the dual bead assay.
  • the reporter beads used in the dual bead assay were 2.1 urn fluorescent beads.
  • the dual beads were formed as discussed in either Fig. 1 1A or 12A.
  • the ligation step is implemented in Step V in Fig. 11A or Step VI in Fig.
  • ligase is added to the dual bead complex solution and allowed to ligate the transport probes to the signal probes.
  • the data shown in Fig. 40 indicates that ligation significantly increases the signal and sensitivity of the assay relative to the non-ligated control treatment in Set 1 but not in Set 2.
  • Fig. 41 is a bar graph showing the number of reporter beads bound in a dual bead complex using a 39mer bridge employing the same ligation step as discussed in Fig. 40.
  • the data in Fig. 41 indicates that ligation significantly increases the sensitivity of the dual bead assay in both Sets 1 and 2.
  • This data demonstrates that the use of a 39mer bridge aids in the ligation process thus enhancing the signal from both Sets as implemented in the dual bead assay.
  • cleavable spacers in dual bead assay increases the specificity of the assay. Indeed, in addition to complementary sequences to the target DNA, the capture probes and reporter probes contain sequences that are complementary to each other. This additional requirement enhances specificity to target capture. Furthermore, additional bonding between the capture bead and reporter beads via the hydrogen bonds between capture and reporter probes strengthen the interactions between the dual beads.
  • the capture probe hybridizes to the reporter probes, resulting in the formation of the dual bead complexes as shown in 42B and 43A.
  • the dual bead complexes are subjected to selective restriction enzyme digestion after target capture. The sequence specific digestion will selectively cleave the hydrogen bonds between the capture probes and reporter probes as depicted in Fig. 42D.
  • the dual beads dissociate from each other. In the presence of target, the capture and reporter beads remain bound via the target-mediated hydrogen bonds (Fig. 42D).
  • the amount of target captured therefore is correlated with the number of dual beads remaining after enzyme digestion.
  • the bond holding the capture probes and reporter probes can be unraveled by the use of a displaceable linker.
  • the linker is detached using a displacement probe.
  • the reporter probe contains a sequence that is partially complementary to the capture probe resulting in a mismatched overhang as depicted in Fig. 43A.
  • the complex is subjected to heat treatment that will initiate the melting of the reporter probe from the capture probe, followed by addition of a large excess of displacement probe.
  • the dual bead assay according to the present invention may be implemented using 3 ⁇ m magnetic capture beads and 2.1 ⁇ m fluorescent reporter beads. These beads are coated with transport probes and signal probes respectively.
  • the transport probes and signal probes in addition to being complementary to a target sequence, pUC19 for example, contain sequences that are complementary to each other, as illustrated in Figs. 42A, 42B, 42C, and 43D.
  • the sequences that bind the transport probe and the signal probes together are designed such that they are susceptible to the cleavage of very rare restriction enzymes including Not 1.
  • the use or rare restriction enzymes and restriction sites prevents the accidental cleavage of the target DNA.
  • the capture beads and reporter beads are mixed with varying quantities of target DNA.
  • the DNA complex is subjected to restriction digestion by a rare restriction enzyme including Not 1.
  • the restriction digestion by this enzyme will cleave the DNA sequence connecting the reporter beads to the capture beads.
  • the reporter beads will be dissociated from the capture beads and removed by magnetic concentration of the magnetic beads.
  • the magnetic capture beads bind to fluorescent reporter beads, resulting in a dual bead assay.
  • the introduction of cleavable spacers into the capture and reporter probes improves the specificity and the sensitivity of the dual bead significantly.
  • a shorter overlap and a mismatched overhang between the complementary sequences of probes on the reporter bead and the capture bead (probe 1 and probe 2B), resulting in the formation of a displaceable linker is used in conjunction with a displacement probe as illustrated in Figs. 43A and 43B.
  • the mismatched overhang on probe 2B is the site for initial binding of the displacement probe as shown in Fig. 42B. Once the displacement probe binds to the overhang, the displacement probe proceeds to displace the overlaping sequences between probe 1 and probe 2B which is depicted in Fig. 43C.
  • the reporter beads In the absence of target DNA, the reporter beads will be dissociated from the capture beads by the actions of the displacement probe and consequently removed by magnetic concentration of the magnetic beads. Thus, only in the presence of the target sequence, the magnetic capture beads bind to fluorescent reporter beads, resulting in the non-dissociation of the dual bead complex.
  • a capture bead is provided with a derivatized surface to which is attached a plurality of cleavable spacer molecules 256.
  • Each spacer 256 including a cleavage site 258, a signal probe 206, and a transport probe 198.
  • the transport probes include a thiol group which reacts to form a covalent bond with metallic elements as discussed in conjunction with Fig. 45.
  • the capture bead which may be porous or solid, can be selected from a variety of materials such as plastics, glass, mica, silicon, and the like.
  • the surface of the capture bead 190 or reporter bead 192 can be conveniently derivatized to provide covalent bonding to each of the probes including the cleavable spacer molecule 256.
  • metallic reporter beads that provide a convenient reflective signal-generating means for detecting the presence of a target.
  • Typical materials used in creating metallic beads are gold, silver, nickel, chromium, platinum, copper, and the like, with gold being presently preferred for its ability readily and tightly to bind e.g. via dative binding to a free SH group at the signal responsive end of the cleavable spacer.
  • the metal beads may be solid metal or may be formed of plastic, or glass beads or the like, on which a coating of metal has been deposited. Also, other reflective materials can be used instead of metal.
  • the presently preferred gold spheres bind directly to the thio group of the signal probe 206.
  • the transport probe 198 is attached covalently at the amino end via an amide linkage.
  • the cleavable spacer molecule includes the cleavage site 258 that is susceptible to cleavage during the assay procedure, by chemical or enzymatic means, heat, light or the like, depending on the nature of the cleavage site.
  • Chemical means are presently preferred with a siloxane cleavage group, and a solution of sodium fluoride or ammonium fluoride, exemplary, respectively, of a chemical cleavage site and chemical cleaving agent.
  • Other groups susceptible to cleaving such as ester groups or dithio groups, can also be used.
  • Dithio groups are especially advantageous if gold spheres are added after cleaving the spacer.
  • the cleavage site may be a restriction site for cleavage using restriction enzymes. Restriction cleavage is the preferred method when performing genetic or immunochemical assays.
  • Spacers may contain two or more cleavage sites to optimize the complete cleavage of all spacers.
  • the transport and signal probes are adapted to bind complementary strands of nucleic acids that may be present in a test sample.
  • the complementary oligonucleotides comprise members of a specific binding pair, i.e., one oligonucleotide will bind to a second complementary oligonucleotide.
  • cleavable spacer molecules 256 including the transport probes 198 and signal probes 206 located at different sites on the surface of the capture bead 190 and reporter bead 192.
  • oligonucleotide target agents 202 are located in close proximity to the transport probes 198 and signal probes 206. In the event these target agents are complimentary to both probes, hybridization occurs between the target agent 202, transport probe 198, and the reporter probes 206 to form a double helix as is shown in Fig. 46B. If there is no complementarity between the target agent 202 and the probes, there is no binding between those groups as is further illustrated in Fig. 46B where no double helix if formed.
  • the reporter beads 192 When the cleavage site 258 is cleaved, but for the binding by the double helix- coupled oligonucleotides, the reporter beads 192 will be free of the capture bead 190 and dissociated therefrom. This is illustrated more fully in Fig. 46C.
  • the presence or absence of dual bead complexes 194 may then be detected by an incident light, particularly an incident laser light.
  • a bridging agent 260 may include a relatively short oligonucleotide sequence for binding to a portion of a target such that when the target binds to the transport 198 and signal probes 206, the bridging agent 260 acts as a bridge between the ends on the transport probe 198 and the signal probe 206. This results in the formation of a double helix with two breaks as depicted in Fig. 47B.
  • Fig. 47C there is shown a schematic representation of the use of DNA ligase in conjunction with the cleavable spacer in a further embodiment of the nucleic acid detection embodiment of the present invention.
  • the ligation procedure links the breaks in the double helix covalently. This covalent linkage increases the strength with which analyte-specific binding adheres the dual bead complex thus permitting, in this embodiment, increased stringency of wash affording increased specificity of the assay.
  • cleavable reflective signal elements of the present invention are particularly well suited for detecting amplified nucleic acids of defined size, particularly nucleic acids amplified using the various forms of polymerase chain reaction (PCR), ligase chain reaction (LCR), amplification schemes using T7 and SP6 RNA polymerase, and the like.
  • PCR polymerase chain reaction
  • LCR ligase chain reaction
  • the cleavable spacer 258 includes modified antibodies to permit an immunoassay.
  • the modified antibodies may be attached non-covalently to the cleavable spacer 258 mediated by oligonucleotides that are covalently attached to the antibodies.
  • Use of complementary nucleic acid molecules to effectuate non-covalent, combinatorial assembly of supramolecular structures is described in further detail in co-owned and co-pending U.S. Patent Applications Serial No. 08/332,514, filed October 31 , 1994; 08/424,874, filed April 19, 1995; and 08/627,695, filed March 29, 1996, incorporated herein by reference.
  • antibodies can be attached covalently to the cleavable spacer using conventional cross-linking agents, either directly or through linkers.
  • the antibody probes include an antibody transport probe 196 bound to the capture bead 190 and an antibody signal probe 208 bound to the reporter bead 192. Both beads and probes are held together by the cleavable spacer 258.
  • the antibody transport probe 196 and the antibody signal probe 208 have affinity to different epitopic sites of an antigen of interest.
  • target antigen 204 binds to the antibody transport probe 196 and the antibody signal probe 208 as shown in Fig. 48B.
  • This binding prevents decoupling of the dual bead complex 194 when the cleavage site 258 is cleaved, such as, for example, by contact with a chemical cleaving agent.
  • the second cleavable signal element which was not bound by the non-specific target agent 200 because the lack of binding affinity of the antibodies to the target agent 200, allow the dual bead complexes to dissociate as illustrated in Fig. 48C.
  • Presence and absence of the dual bead complex 194 may then be detected as reflectance or absence of reflectance of incident light, particularly incident laser light.
  • the present invention will prove particularly valuable in immunoassays screening for human immunodeficiency viruses, hepatitis a virus, hepatitis B virus, hepatitis C virus, and human herpes viruses.
  • antibodies are exemplary of the broader concept of specific binding pairs, wherein the antibody may be considered the first member of the specific binding pair, and the antigen to which it binds the second member of the specific binding pair.
  • a specific binding pair may be defined as two molecules, the mutual affinity of which is of sufficient avidity and specificity to permit the practice of the present invention.
  • the cleavable spacer of the present invention may include other specific binding pair members as side members.
  • the first side member of the cleavable signal element includes a first member of a first specific binding pair
  • the second side member of the cleavable spacer includes a first member of a second specific binding pair
  • said second member of said first specific binding pair and said second member of said second specific binding pair are connectably attached to one another, permitting the formation of a tethering loop of the general formula: first member of first specific binding pair-second member of first specific binding pair- second member of second specific binding pair-first member of second specific binding pair.
  • biologic receptors and their natural agonist and antagonist ligands, proteins and cofactors, biotin and either avidin or streptavidin, alpha spectrin and beta spectrin monomers, and antibody Fc portions and Fc receptors.
  • A. Dual Bead Assay In this example, the dual assay in carried out to detect the gene sequence
  • the assay is comprised of 3 ⁇ magnetic and capture beads coated with covalently attached capture probe; 2.1 ⁇ fluorescent reporter beads coated with a covalently attached sequence specific for the DYS gene, and target DNA molecule containing DYS sequences.
  • the target DNA is a synthetic 80 oligonucleotide sequence.
  • the capture probe and reporter probes are 40 nucleotides in length and are complementary to DYS sequence but not to each other.
  • the specific methodology employed to prepare the assay involved treating 1x10 7 capture beads and 2x1 o 7 reporter beads in 100 microgram per milliliter Salmon Sperm DNA for 1 hr. at room temperature. This pretreatment will reduce non- covalent binding between the capture and reporter beads in the absence of target DNA as shown in Fig. 38.
  • the capture beads were concentrated magnetically with the supernatant being removed.
  • a 100 microliter volume of the hybridization buffer (0.2 M NaCI, 1 mM EDTA, 10 mM MgCI 2 , 50 mM Tris HCI, pH 7.5, and 5X Denhart's mixture, 10 microgram per milliliter denatured salmon sperm DNA) were added to the capture beads and the beads were re-suspended.
  • Various concentrations of target DNA ranging from 1 , 10, 100, 1000 femtomoles were added while mixing at 37°C for 2 hours.
  • the beads were magnetically concentrated and the supernatant containing target DNA was removed.
  • a 100 microliter volume of wash buffer (145mM NaCI, 50 mM Tris pH 7.5, 0.1 % SDS, 0.05 % Tween, 0.25 % NFDM, 10 mM EDTA) was added and the beads were re-suspended. The beads were magnetically concentrated and the supernatant was again removed. The wash procedure was repeated twice.
  • a 2x10 7 amount of reporter beads in 100 microliter hybridization buffer ( 0.2 M NaCI, 1 mM EDTA, 10 mM MgCI 2 , 50 mM Tris HCI, pH 7.5, and 5X Denhart's mixture, 10 microgram per milliliter denatured salmon sperm DNA) were then added to washed capture beads. The beads were re-suspended and incubated while mixing at 37°C for an additional 2 hours. After incubation the capture beads were concentrated magnetically, and the supernatant containing unbound reporter beads were removed.
  • wash buffer 145mM NaCI, 50 mM Tris pH 7.5, 0.1 % SDS, 0.05 % Tween, 0.25 % NFDM, 10 mM EDTA
  • the beads were re-suspended in 20 microliters of binding buffer (50 mM Tris, 200mM NaCI, 10 mM MgCI 2 , 0.05% Tween 20, 1% BSA). A 10 microliter volume was loaded on to the disc that was prepared as described below in Part B of this example.
  • binding buffer 50 mM Tris, 200mM NaCI, 10 mM MgCI 2 , 0.05% Tween 20, 1% BSA.
  • a capture zone could be created with the capture agent such as BSA Biotin which could be immobilized on to the disc (pretreated with Polystyrene) by passive absorption.
  • a perspective view of the disc assembly showing the use of biotin capture agents is presented in Figs. 26A-26D.
  • Various methods for use in this type of anchoring of beads onto the disc are also shown in Figs. 15A-15B, 17, 19A-19C, and 23A-23B.
  • a 10 microliter volume of the dual bead mixture prepared as described in Part A above was loaded in to the disc chamber and the injection ports were sealed.
  • the disc was centrifuged at low speed (less than 800 rpm) upto 15 minutes.
  • the disc was read in the CD reader at the speed 4X (approx. 1600 rpm) for 5 minutes. Under these conditions, the unbound magnetic capture beads were centrifuged away from the capture zone.
  • the magnetic capture beads that were in the dual bead complex remained bound to the reporter beads in the capture zone.
  • the steps involved in using the disc to capture and analyze dual bead complexes are presented in detail in Figs. 25A-25D, 26A-26D, and 27A-27D.
  • the amount of target DNA captured could be enumerated by quantifying the number of capture magnetic beads and the number of reporter beads since each type of bead has a distinct signature.
  • the dual bead assay is carried out to detect two DNA targets simultaneously.
  • the assay is comprised of 3 ⁇ magnetic capture bead.
  • One population of the magnetic capture bead is coated with capture probes 1 which are complementary to the DNA target 1
  • another population of magnetic capture beads is coated with capture probes 2 which are complementary to the DNA target 2.
  • two different types of magnetic capture beads may be used.
  • Various combinations of beads that may be used in a multiplex dual bead assay format are depicted in Fig. 32.
  • One type of reporter bead is coated with reporter probes 1 , which are complementary to the DNA target 1.
  • the other reporter beads are coated with reporter probes 2, which are complementary to the DNA target 2. Again the capture probes and the reporter probes are complementary to the respective targets but not to each other.
  • the specific methodology employed to prepare the dual bead assay multiplexing involved treating 1x10 7 capture beads and 2x10 7 reporter beads in 100 ⁇ g/ml salmon sperm DNA for 1 hour at room temperature. This pretreatment will reduce non-covalent binding between the capture and reporter beads in the absence of target DNA.
  • the capture beads were concentrated magnetically with the supernatant being removed.
  • a 100 microliter volume of the hybridization buffer (0.2 M NaCI, 1 mM EDTA, 10 mM MgCI 2 , 50 mM Tris HCI, pH 7.5, and 5X Denhart's mixture, 10 microgram per milliliter denatured salmon sperm DNA) were added and the beads were re-suspended.
  • Various concentrations of target DNA ranging from 1 , 10, 100, 1000 femto moles were added to the capture beads suspension. The suspension was incubated while mixing at 37°C for 2 hours. The beads were magnetically concentrated and the supernatant containing target DNA was removed. A 100 microliter volume of wash buffer (145mM NaCI, 50 mM Tris pH 7.5, 0.1% SDS, 0.05 % Tween, 0.25 % NFDM, 10 mM EDTA) was added and the beads were re-suspended. The beads were magnetically concentrated and the supernatant was again removed. The wash procedure was repeated twice.
  • wash buffer 145mM NaCI, 50 mM Tris pH 7.5, 0.1% SDS, 0.05 % Tween, 0.25 % NFDM, 10 mM EDTA
  • a 2x10 7 amount of reporter beads in 100 microliter hybridization buffer (0.2 M NaCI, 1 mM EDTA, 10 mM MgCI 2 , 50 mM Tris HCI, pH 7.5, and 5X Denhart's mixture, 10 microgram per milliliter denatured salmon sperm DNA) were then added to washed capture beads. The beads were re-suspended and incubated while mixing at 37°C for an additional 2 hours. After incubation the capture beads were concentrated magnetically, and the supernatant containing unbound reporter beads were removed.
  • wash buffer 145mM NaCI, 50 mM Tris pH 7.5, 0.1% SDS, 0.05 % Tween, 0.25 % NFDM, 10 mM EDTA
  • the beads were re-suspended in 20 microliters of binding buffer (50 mM Tris, 200mM NaCI, 10 mM MgCI 2 , 0.05% Tween 20, 1 % BSA). A 10 microliter volume of this solution was loaded on to the disc that was prepared as described in below in Part B of this example.
  • binding buffer 50 mM Tris, 200mM NaCI, 10 mM MgCI 2 , 0.05% Tween 20, 1 % BSA.
  • Distinct reaction zones were created for two types of reporter beads. Each reaction zone consisted of amine DNA sequences complementary to the respective reporter probes (or capture agents). Prior to sample injection, the channel were blocked with a blocking buffer (50mM Tris, 200mM NaCI, 10 mM MgCI 2 , 0.05% Tween 20, 1 % BSA, 1 % sucrose) to prevent non-covalent binding of the dual bead complex to the disc surface.
  • a blocking buffer 50mM Tris, 200mM NaCI, 10 mM MgCI 2 , 0.05% Tween 20, 1 % BSA, 1 % sucrose
  • magnetic beads employed in a multiplexing dual bead assay format may be detected using a magneto-optical disc and drive.
  • the chemical reaction zones, in the magnetic disc format are replaced by distinctly spaced magnetic capture zones as discussed in conjunction with Fig. 37, see below Examples 5 and 6.
  • the disc was centrifuged at low speed (less than 800 rpm) for up to 15 minutes.
  • the disc was read in the CD reader at the speed 4X (approx. 1600 rpm) for 5 minutes. Under these conditions, the unbound magnetic capture beads were centrifuged to the bottom of the channels.
  • the reporter beads bound to the capture zone via hybridization between the reporter probes and their complementary agent.
  • the amount of target DNA 1 and 2 captured could be enumerated by quantifying the number of the respective reporter beads in the respective reaction zones.
  • EXAMPLE 3 The sensitivity of the dual bead assay depends on the strength of the target mediated-bonds holding the dual beads together.
  • the dual beads are held together by hydrogen bonds. The strength of the bond would increase significantly if the bond holding the dual beads is covalent.
  • a ligation reaction is carried out to create a covalent bond between the capture and reporter probes as illustrated above in Fig. 38.
  • the 5' end of the reporter probe carries a phosphate group which is required in the ligation reaction.
  • the assay is comprised of 3 ⁇ m magnetic capture beads (Spherotech, Libertyville, IL) coated with covalently attached capture probes; 2.1 ⁇ m fluorescent reporter beads (Molecular Probes, Eugene, OR) coated with a covalently attached sequence specific for the DYS gene, and target DNA molecules containing DYS sequences.
  • the target DNA is a synthetic 80 oligonucleotide long.
  • the capture probes and reporter probes are 40 nucleotides in length and are complementary to the DYS sequence but not to each other.
  • the specific methodology employed to prepare the assay involved treating 1x10 7 capture beads and 2x10 7 reporter beads in 100 ⁇ g/ml salmon sperm DNA for 1 hour at room temperature. This pre-treatment will reduce the non-specific binding between the capture and reporter beads in the absence of target DNA.
  • the capture beads were concentrated magnetically with the supernatant being removed. Then 100 ⁇ l of the hybridization buffer (0.2M NaCI, 1 M EDTA, 10mM MgCI 2 , 50mM Tris- HCI, pH 7.5 and 5X Denhart's mix, 10 ⁇ g/ml denatured salmon sperm DNA) was added and the beads Were resuspended.
  • Various concentration of target DNA ranging from 1 , 10, 100, and 1000 femtomoles were added to the capture bead suspensions.
  • the beads suspension was incubated while mixing at 37 degrees Centigrade for 2 hours.
  • the beads were magnetically concentrated and the supernatant containing unbound target DNA was removed.
  • One hundred microliters of wash buffer (145mM NaCI, 50mM Tris, pH 7.5, 0.1 % SDS, 0.05% Tween, 0.25% NFDM (Non Fat Dried Milk), 10mM EDTA) was added and the beads were resuspended.
  • the beads were magnetically concentrated and the supernatant was again removed.
  • the wash procedure was repeated twice.
  • a 2x10 7 amount of reporter beads in 100 ⁇ l hybridization buffer (0.2M NaCI, 1 mM EDTA, 10mM MgCI 2 , 50mM Tris-HCI, pH 7.5 and 5X Denhart's mix, 10 ⁇ g/ml denatured salmon sperm DNA) was then added to washed capture beads.
  • the beads were resuspended and incubated while mixing at 37 degrees Centigrade for an additional 2 hours. After incubation, the capture beads were concentrated magnetically, and the supernatant containing unbound reporter beads were removed.
  • wash buffer 145mM NaCI, 50mM Tris, pH 7.5, 0.1 % SDS, 0.05% Tween, 0.25% NFDM (Non Fat Dried Milk), 10mM EDTA
  • wash buffer 145mM NaCI, 50mM Tris, pH 7.5, 0.1 % SDS, 0.05% Tween, 0.25% NFDM (Non Fat Dried Milk), 10mM EDTA
  • the specific methodology employed to prepare the above assay involved treating 1x10 7 capture beads and 2x10 7 reporter beads in 100 ⁇ g/ml salmon sperm DNA for 1 hour at room temperature. This pre-treatment will reduce the non-specific binding between the capture and reporter beads in the absence of target DNA.
  • the capture beads were concentrated magnetically with the supernatant being removed. Then 100 ⁇ l of the hybridization buffer (0.2M NaCI, 1 mM EDTA, 10mM MgCI 2 , 50mM Tris-HCI, pH 7.5 and 5X Denhart's mix, 10 ⁇ g/ml denatured salmon sperm DNA) was added and the beads were resuspended.
  • Various concentrations of target DNA ranging from 1 , 10, 100, and 1000 femtomoles were added to the capture bead suspensions.
  • the beads suspension was incubated while mixing at 37 degrees Centigrade for 2 hours.
  • the beads were magnetically concentrated and the supernatant containing unbound target DNA was removed.
  • One hundred microliters of wash buffer (145mM NaCI, 50mM Tris, pH 7.5, 0.1 % SDS, 0.05% Tween, 0.25% NFDM (Non Fat Dried Milk), 10mM EDTA) was added and the beads were resuspended.
  • the beads were magnetically concentrated and the supernatant was again removed.
  • the wash procedure was repeated twice.
  • a 2x10 7 amount of reporter beads or 100 pmoles of reporter probes in 100 ⁇ l hybridization buffer (0.2M NaCI, 1 mM EDTA, 10mM MgCI 2 , 50mM Tris-HCI, pH 7.5 and 5X Denhart's mix, 10 ⁇ g/ml denatured salmon sperm DNA ) was then added to washed capture beads.
  • the beads were resuspended and incubated while mixing at 37 degrees Centigrade for an additional 2 hours. After incubation, the capture beads were concentrated magnetically, and the supernatant containing unbound reporter beads or unbound reporter probes were removed.
  • wash buffer 145mM NaCI, 50mM Tris, pH 7.5, 0.1 % SDS, 0.05% Tween, 0.25% NFDM (Non Fat Dried Milk), 10mM EDTA
  • wash buffer 145mM NaCI, 50mM Tris, pH 7.5, 0.1 % SDS, 0.05% Tween, 0.25% NFDM (Non Fat Dried Milk), 10mM EDTA
  • a 10 ⁇ L volume of the 10X ligation buffer (final concentration 66mM Tris, pH 7.6, 6.6mM MgCI 2 , 100mM DTT, 66 ⁇ M ATP) and 4 units ligase (concentrations 10 units per ⁇ L) was added to the bead suspensions.
  • the ligation reaction was carried out for 2 hours at room temperature.
  • the bead suspensions were washed 3 times with wash buffer (145mM NaCI, 50mM Tris, pH 7.5, 0.2 %SDS, 0.05 % Tween 20, 0.25 % NFDM). In the control tube, no ligase was added.
  • the amount of reporter probe was directly correlated with the amount of target DNA captured. Therefore, one way to quantify the target captured was to quantify the amount of reporter probe.
  • the rationale for this assay is that the reporter probe was biotinylated. The concentrations of the reporter probe therefore could be determined by an enzyme assay wherein the enzyme Streptavidin-Alkaline phosphatase binds to the biotin moiety.
  • a chromogenic substrate for Alkaline phosphatase, p-nitrophenyl phosphate was used as reporter. This colorless substrate is hydrolyzed by alkaline phosphatase to a yellow product which has an absorbance at 405nm.
  • the beads were washed with 100 ⁇ l of CDB (2% BSA, 50mM Tris-HCI, pH 7.5, 145mM NaCI, 1.0 mM MgCI 2 , 0,1 mM ZnCI 2 , 0.05% NaN 3 ) and incubated with 100 ⁇ l of 250ng/ml Streptavidin-Phosphatase for 1 hour at 37°C.
  • the beads were washed 3 times with wash buffer (145mM NaCI, 50mM Tris, pH 7.5, 0.05% Tween) to get rid of unbound S-AP.
  • the beads were incubated with 100 ⁇ l of the S-AP substrate p-nitrophosphate at 3.7mg/ml in 0.1 M Tris, pH 10, 2mM MgCI 2 for 5-15 minutes at room temperature.
  • the color development of the supernatant was monitored at 405nm. The intensity of the color is directly correlated with the amount of the biotinylated reporter probe and thus the amount of target captured.
  • cleavable spacers in dual bead assay increases the specificity of the assay.
  • the following example is directed to a dual bead assay using cleavable spacers.
  • the design of capture probes and reporter probes is critical in the success of the dual bead assay using cleavable spacers.
  • the capture probes and reporter probes contain 3 branches as illustrated above in Fig.
  • One branch of the reporter or capture probes participates in the target capture.
  • Several linkers PEG groups
  • the second branch of the capture or reporter probes contains 3 linkers followed by a biotin at the end.
  • Other functional groups such as carboxyl or amine could also be used.
  • the biotin participates in the conjugation of the capture or reporter probes onto the solid phase.
  • the third branch of the capture probe hybridizes to the reporter probe.
  • restriction enzyme digestion is the method of choice for cleaving the capture and reporter probes
  • a restriction site is introduced into the sequences of the probes.
  • the choice of restriction site is important in that it has to be unique (not common) so that only the sequence holding the capture and reporter probes (and not the target DNA) is cleaved.
  • the formation of the capture and reporter probes in the presence of the target is shown above in Fig. 42C.
  • the first step in the assay is the conjugation of the capture probe onto a solid phase.
  • 2.8 ⁇ m magnetic beads coated with streptavidin from Dynal were used as the solid phase.
  • 6.7x10 7 Dynal beads were used per conjugation.
  • the beads were resuspended in 200 ⁇ l of binding and washing buffer (l Om Tris-HCI, pH 7.5, 1 mM EDTA, 2M NaCI). The beads were magnetically concentrated and the supernatant was removed. The wash procedure was repeated twice.
  • Blocking of remaining streptavidin sites on the bead The beads were incubated in 400 ⁇ l of PBS containing 2mg/ ml biotin for 1 hour on a rotating mixer to block all remaining streptavidin sites on the Dynal magnetic beads.
  • the magnetic beads were washed 3 times with binding and washing buffer (10mM Tris-HCI, pH 7.5, 1 mM EDTA, 2M NaCI) and resuspended in 1000 ⁇ l hybridization buffer (0.2M NaCI, 10mM MgCI 2 , 1 mM EDTA, 50mM Tris, pH 7.5).
  • Amount of biotinylated capture probe 1 bound to 1 mg of bead 127 pmoles or 8 x 10 13 molecule
  • the beads were washed with 100 ⁇ l of CDB (2% BSA, 50mM Tris-HCI, pH 7.5, 145mM NaCI, 1.0mM MgCI 2 , 0,1 mM ZnCI 2 , 0.05% NaN 3 ) and incubated with 100 ⁇ l of 250ng/ml Streptavidin-Phosphatase for 1 hour at 37°C.
  • the beads were washed 3 times with wash buffer (145mM NaCI, 50mM Tris, pH 7.5, 0.05% Tween) to get rid of unbound S-AP.
  • the beads were incubated with 100 ⁇ l of the S-AP substrate p-nitrophosphate at 3.7mg/ml in 0.1 M Tris, pH 10, 2mM MgCI 2 for 5-15 minutes at room temperature.
  • the color development of the supernatant was monitored at 405nm.
  • the intensity of the color is directly correlated with the amount of the biotinylated reporter probe 2A or 2B hybridized.
  • the reporter probes could be attached to another solid phase via their biotin moiety.
  • a different type of streptavidin coated beads i.e. polystyrene or fluorescent, is added to the bead suspension, resulting in the formation of the dual bead complexes. If the solid phase is the surface of the bio-disc, then the mixture of capture and reporter probes is incubated on a streptavidin coated disc surface.
  • Hybridization In this example, the target DNA was a single stranded 80mer oligonucleotide. Various concentrations of target DNA ranging from 0, 1 , and 1000 picomoles were added to the bead suspensions. The beads suspensions were incubated while mixing at 37 degrees Centigrade for 2 hours.
  • wash buffer 145mM NaCI, 50mM Tris, pH 7.5, 0.1% SDS, 0.05% Tween, 0.25% NFDM (Non Fat Dried Milk), 10mM EDTA
  • wash buffer 145mM NaCI, 50mM Tris, pH 7.5, 0.1% SDS, 0.05% Tween, 0.25% NFDM (Non Fat Dried Milk), 10mM EDTA
  • restriction enzyme digestion The restriction enzyme site that was introduced in the capture and reporter probes was NOTL This restriction enzyme site is rare and in this model system is not found in any other sites.
  • the beads were resuspended in 400 ⁇ l CDB (2% BSA, 50mM Tris-HCI, pH 7.5, 145mM NaCI, 1.0 mM MgCI 2 , 0,1 mM ZnCI 2 , 0.05% NaN 3 ).
  • the bead suspension was aliquoted into seven tubes, one control and 6 digestion tubes.
  • the enzyme NOT1 was prepared according to the manufacturer's specifications. Then 5 units of enzyme were added to the each digestion tubes in a total volume of 100 ⁇ l. Water was added to the control tube. The digestion was carried out for 3-4 hours at 37°C.
  • Displacement of the reporter probe by the displacement probe The beads were resuspended in 400 ⁇ l CDB (2% BSA, 50mM Tris-HCI, pH 7.5, 145mM NaCI, 1.0 mM MgCI 2 , 0,1 mM ZnCI 2 , 0.05% NaN 3 ). The bead suspension was aliquoted into two tubes, one control and one displacement tube. The beads were heated for 5 minutes at 55°C in 200 ⁇ l of 6xSSC, 1 mM EDTA. The heat treatment was used to induce the melting of the reporter probe 2B from the capture probe. At this point, a 10 fold excess of displacement probe was added to the bead suspension and the mixture was incubated at 37°C for several hours Water was added to the control tube.
  • the amount of reporter probe remaining after the restriction enzyme digestion or probe displacement was directly correlated with the amount of target DNA captured. Therefore, one way to quantify the target captured was to quantify the amount of remaining reporter probe.
  • the rationale for this assay is that the reporter probes 2A and 2B were biotinylated. The concentrations of these probes therefore could be determined by an enzyme assay wherein the enzyme Streptavidin-Alkaline phosphatase binds to the biotin moiety.
  • a chromogenic substrate for Alkaline phosphatase, p-nitrophenyl phosphate was used as reporter. This colorless substrate is hydrolyzed by alkaline phosphatase to a yellow product which has an absorbance at 405nm.
  • the beads were washed with 100 ⁇ l of CDB (2% BSA, 50mM Tris-HCI, pH 7.5, 145mM NaCI, 1.0 mM MgCI 2 , 0,1mM ZnCI 2 , 0.05% NaN 3 ) and incubated with 100 ⁇ l of 250ng/ml Streptavidin-Phosphatase for 1 hour at 37°C.
  • the beads were washed 3 times with wash buffer (145mM NaCI, 50mM Tris, pH 7.5, 0.05% Tween) to get rid of unbound S-AP.
  • the beads were incubated with 100 ⁇ l of the S-AP substrate p-nitrophosphate at 3.7mg/ml in 0.1 M Tris, pH 10, 2mM MgCI 2 for 5-15 minutes at room temperature. The color development of the supernatant was monitored at 405nm. The intensity of the color is directly correlated with the amount of the biotinylated reporter probe 2A or 2B hybridized.
  • the amount of target captured could be quantified by dual bead assay.
  • the number of reporter beads remaining following restriction enzyme digestion or probe displacement could be enumerated by the fluorimeter (for fluorescent beads) or by the bio-CD reader since each type of bead has a distinct signal signature.
  • the following example illustrates a dual bead assay carried out on a magnetically writable and erasable analysis disc such as the magneto-optical bio- disc 1 10 discussed in conjunction with Fig. 37.
  • the dual bead assay is carried out to detect the gene sequence DYS which is present in male but not female.
  • the assay is comprised of 3 ⁇ m magnetic capture beads (Spherotech, Libertyville, IL) coated with covalently attached transport probes; 2.1 ⁇ m fluorescent reporter beads (Molecular Probes, Eugene, OR) coated with a covalently attached sequence specific for the DYS gene, and target DNA molecules containing DYS sequences.
  • the target DNA is a synthetic 80 oligonucleotides long.
  • the transport probes and reporter probes are 40 nucleotides in length and are complementary to the DYS sequence but not to each other.
  • the specific methodology employed to prepare the assay involved treating 1x10 7 capture beads and 2x10 7 reporter beads in 100 ⁇ g/ml salmon sperm DNA for 1 hour at room temperature. This pre-treatment will reduce the non-specific binding between the capture and reporter beads in the absence of target DNA.
  • the capture beads are loaded inside the MO bio-disc via the injection port.
  • the MO bio-disc contains magnetic regions created by the magneto optical drive. The capture beads thus are held within specific magnetic regions on the MO bio-disc.
  • the sample containing target DNA and reporter beads in 200 ⁇ l hybridization buffer (0.2M NaCI, 1 mM EDTA, 10mM MgCI 2 , 50mM Tris-HCI, pH 7.5 and 5X Denhart's mix, 10 ⁇ g/ml denatured salmon sperm DNA) is then added to the MO bio- disc via the injection port. The injection port is then sealed. The magnetic field is released. The disc is rotated at very low speed (less than 800rpm) in the drive to facilitate hybridization of target DNA and reporter beads to the capture beads. The temperature of the drive is kept constant at 33 degrees Centigrade. After 2 hours of hybridization, the magnetic field is created by the magneto optical drive.
  • Unbound target and reporter beads are directed to a waste chamber by any of the mechanisms described above.
  • Two hundred microliters of wash buffer (145mM NaCI, 50mM Tris, pH 7.5, 0.1 % SDS, 0.05% Tween, 0.25% NFDM (Non Fat Dried Milk), 10mM EDTA) is then added.
  • the magnetic field is released and the disc is rotated at low speed (less than 800rpm) for 5 minutes to remove any non-specific binding between the capture beads and reporter beads.
  • the magnetic field is then reapplied.
  • the wash buffer is directed to the waste chamber by any of the mechanisms described above. The wash procedure is repeated twice.
  • a dual bead assay using the multiplexing techniques described above in connection with Figs. 32 and 37 is carried out on a magnetically writable and erasable analysis disc such as the MO bio-disc 1 10 discussed with reference to Fig. 37.
  • the dual bead assay is carried out to detect 2 or more DNA targets simultaneously.
  • the assay is comprised of 3 ⁇ m magnetic capture beads (Spherotech, Libertyville, IL).
  • One population of the magnetic capture beads is coated with transport probes 1 which are complementary to the DNA target 1.
  • Another population of the magnetic capture beads is coated with transport probes 2 which are complementary to the DNA target 2.
  • 2 or more different types of magnetic capture beads may be used.
  • the reporter beads may differ by chemical composition (for example silica and polystyrene) and/or by size.
  • One type of reporter beads is coated with reporter probes 1 , which are complementary to the DNA target 1.
  • the other reporter beads are coated with reporter probes 2, which are complementary to the DNA target 2.
  • the transport probes and reporter probes are complementary to the respective targets but not to each other.
  • the specific methodology employed to prepare the dual bead assay multiplexing involved treating 1x10 7 capture beads and 2x10 7 reporter beads in 100 ⁇ g/ml salmon sperm DNA for 1 hour at room temperature. This pre-treatment will reduce the non-specific binding between the capture and reporter beads in the absence of target DNA.
  • the capture beads are loaded in the MO bio-disc.
  • the magnetic field is applied to create distinct magnetic zones for specific capture beads.
  • the capture beads can be held on the MO bio-disc at a density of 1 capture bead per 10 ⁇ m 2 .
  • the surface area usable for bead deposition on the MO bio-disc is approximately 3 x 10 9 ⁇ m 2 .
  • the capacity of the MO bio-disc for 3 ⁇ m beads at the given density is about 3 x 10 8 beads.
  • the sample containing the targets DNA of interest is mixed with different types of reporter beads in 200 ⁇ l hybridization buffer (0.2M NaCI, 1 mM EDTA, 10mM MgCI 2 , 50mM Tris-HCI, pH 7.5 and 5X Denhart's mix, 10 ⁇ g/ml denatured salmon sperm DNA) and added to the MO bio-disc via the injection port.
  • the injection port is then sealed.
  • the magnetic field is released.
  • the disc is rotated at very low speed (less than 800rpm) in the drive to facilitate hybridization of targets DNA and reporter beads to the different types of capture beads.
  • the temperature of the drive is kept constant at 33 degrees Centigrade. After 2 to 3 hours of hybridization, the magnetic field is regenerated by the magneto optical drive.
  • the magnetic field is released and the dual bead complexes are directed to a detection chamber.
  • the amount of different types of target DNA can be enumerated by quantifying the number of corresponding capture magnetic beads
  • any of the off-disc preparation procedures may be readily performed on-disc by use of suitable fluidic circuits employing the methods described herein.
  • any of the fluidic circuits discussed in connection with the reflective and transmissive discs may be readily adapted to the MO bio-disc.
  • the scope of the present invention is not solely limited to the formation of only dual bead complexes.
  • the methods and apparatus hereof may be readily applied to the creation of multi-bead assays.
  • a single capture bead may bind multiple reporter beads.
  • a single reporter bead may bind multiple capture beads.
  • linked chains of multi-bead or dual bead complexes may be formed by target mediated binding between capture and reporter beads. The linked chains may further agglutinate to thereby increase detectability of a target agent of interest.

Abstract

L'invention concerne des procédés permettant de réduire des liaisons non-spécifiques de perles dans des essais biologiques à deux perles; des disques biologiques optiques associés et des lecteurs de disques associés. Les procédés décrits dans cette invention consistent à déterminer l'utilité d'une phase solide d'essai dans un essai biologique à deux perles. Le procédé décrit dans l'invention consiste également à identifier la présence d'un agent cible dans un échantillon biologique, et à mélanger les perles de capture, les perles de marquage et un échantillon biologique. Le mélange est réalisé dans des conditions de liaison de manière à permettre la formation d'un complexe à deux perles si l'agent cible est présent dans l'échantillon. La perle de marquage et la perle de capture sont chacune fixée à un agent cible. Des espaceurs clivables ou des lieurs de déplacement peuvent être utilisés pour former des complexes à deux perles. Les procédés décrits dans la présente invention consistent également à placer les perles de capture et les perles de marquage à proximité les unes des autres, par déclenchement d'une réaction de ligature au moyen d'une ligase, puis à isoler le complexe à deux perles du mélange de manière à obtenir un isolat. L'isolat est exposé à un champ de capture sur un disque, le champ de capture comprenant un agent de capture qui se fixe au complexe à deux billes. La réaction de ligature permet une fixation par liaison covalente entre une sonde de capture et une sonde de marquage. La réaction de ligature permet également d'améliorer la sensibilité de l'essai biologique à deux perles.
PCT/US2002/008208 2001-03-14 2002-03-14 Essai biologique a deux perles utilisant des espaceurs clivables et/ou la ligature pour ameliorer la specificite et la sensibilite, procedes et dispositifs associes WO2002073605A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002306750A AU2002306750A1 (en) 2001-03-14 2002-03-14 Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US27564301P 2001-03-14 2001-03-14
US60/275,643 2001-03-14
US27868801P 2001-03-26 2001-03-26
US27869401P 2001-03-26 2001-03-26
US60/278,694 2001-03-26
US60/278,688 2001-03-26
US09/911,253 2001-07-23
US09/911,253 US20020106661A1 (en) 1996-07-08 2001-07-23 Optical disk-based assay devices and methods
US31490601P 2001-08-24 2001-08-24
US60/314,906 2001-08-24
US09/997,741 2001-11-27
US09/997,741 US20030003464A1 (en) 2000-11-27 2001-11-27 Dual bead assays including optical biodiscs and methods relating thereto
US10/038,297 US20030077598A1 (en) 2001-01-04 2002-01-04 Dual bead assays including covalent linkages for improved specificity and related optical analysis discs
US10/038,297 2002-01-04
US35227002P 2002-01-30 2002-01-30
US60/352,270 2002-01-30

Publications (2)

Publication Number Publication Date
WO2002073605A2 true WO2002073605A2 (fr) 2002-09-19
WO2002073605A3 WO2002073605A3 (fr) 2003-04-03

Family

ID=27574254

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/008208 WO2002073605A2 (fr) 2001-03-14 2002-03-14 Essai biologique a deux perles utilisant des espaceurs clivables et/ou la ligature pour ameliorer la specificite et la sensibilite, procedes et dispositifs associes

Country Status (1)

Country Link
WO (1) WO2002073605A2 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002042498A2 (fr) * 2000-11-27 2002-05-30 Burstein Technologies, Inc. Analyses a l'aide de complexe a deux billes, biodisques optiques, et procedes d'analyse
WO2003087827A2 (fr) * 2001-04-11 2003-10-23 Burstein Technologies, Inc. Dosages a parametres multiples mettant en oeuvre des disques d'analyse, et procedes s'y rapportant
WO2007005076A1 (fr) * 2005-07-05 2007-01-11 3M Innovative Properties Company Système de commande de valve pour dispositif de détection de fluorescence multiplexe rotatif
US7507575B2 (en) 2005-04-01 2009-03-24 3M Innovative Properties Company Multiplex fluorescence detection device having removable optical modules
US7709249B2 (en) 2005-04-01 2010-05-04 3M Innovative Properties Company Multiplex fluorescence detection device having fiber bundle coupling multiple optical modules to a common detector

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102046807B (zh) 2008-04-24 2014-11-26 3M创新有限公司 利用小波变换分析核酸扩增曲线

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998001533A1 (fr) * 1996-07-08 1998-01-15 Burstein Laboratories, Inc. Procede et dispositif a element de signal clivable
WO1998038510A2 (fr) * 1997-02-28 1998-09-03 Burstein Laboratories, Inc. Laboratoire sur disque
WO2000005582A2 (fr) * 1998-07-21 2000-02-03 Burstein Laboratories, Inc. Dispositifs de dosage utilisant des disques optiques et methodes correspondantes
WO2002042498A2 (fr) * 2000-11-27 2002-05-30 Burstein Technologies, Inc. Analyses a l'aide de complexe a deux billes, biodisques optiques, et procedes d'analyse

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998001533A1 (fr) * 1996-07-08 1998-01-15 Burstein Laboratories, Inc. Procede et dispositif a element de signal clivable
WO1998038510A2 (fr) * 1997-02-28 1998-09-03 Burstein Laboratories, Inc. Laboratoire sur disque
WO2000005582A2 (fr) * 1998-07-21 2000-02-03 Burstein Laboratories, Inc. Dispositifs de dosage utilisant des disques optiques et methodes correspondantes
WO2002042498A2 (fr) * 2000-11-27 2002-05-30 Burstein Technologies, Inc. Analyses a l'aide de complexe a deux billes, biodisques optiques, et procedes d'analyse

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002042498A2 (fr) * 2000-11-27 2002-05-30 Burstein Technologies, Inc. Analyses a l'aide de complexe a deux billes, biodisques optiques, et procedes d'analyse
WO2002042498A3 (fr) * 2000-11-27 2003-07-31 Burstein Technologies Inc Analyses a l'aide de complexe a deux billes, biodisques optiques, et procedes d'analyse
WO2003087827A2 (fr) * 2001-04-11 2003-10-23 Burstein Technologies, Inc. Dosages a parametres multiples mettant en oeuvre des disques d'analyse, et procedes s'y rapportant
WO2003087827A3 (fr) * 2001-04-11 2004-03-18 Burstein Technologies Inc Dosages a parametres multiples mettant en oeuvre des disques d'analyse, et procedes s'y rapportant
US7507575B2 (en) 2005-04-01 2009-03-24 3M Innovative Properties Company Multiplex fluorescence detection device having removable optical modules
US7709249B2 (en) 2005-04-01 2010-05-04 3M Innovative Properties Company Multiplex fluorescence detection device having fiber bundle coupling multiple optical modules to a common detector
WO2007005076A1 (fr) * 2005-07-05 2007-01-11 3M Innovative Properties Company Système de commande de valve pour dispositif de détection de fluorescence multiplexe rotatif
CN101218496A (zh) * 2005-07-05 2008-07-09 3M创新有限公司 用于旋转多元荧光探测设备的阀门控制系统
US7527763B2 (en) 2005-07-05 2009-05-05 3M Innovative Properties Company Valve control system for a rotating multiplex fluorescence detection device
US7867767B2 (en) 2005-07-05 2011-01-11 3M Innovative Properties Company Valve control system for a rotating multiplex fluorescence detection device

Also Published As

Publication number Publication date
WO2002073605A3 (fr) 2003-04-03

Similar Documents

Publication Publication Date Title
US20030054376A1 (en) Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
US20030082568A1 (en) Use of restriction enzymes and other chemical methods to decrease non-specific binding in dual bead assays and related bio-discs, methods, and system apparatus for detecting medical targets
US20020168663A1 (en) Methods for DNA conjugation onto solid phase including related optical biodiscs and disc drive systems
US20020172980A1 (en) Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
US20060068409A1 (en) Use of restriction enzymes and other chemical methods to decrease non-specific binding in dual bead assays and related bio-discs, methods, and system apparatus for detecting medical targets
US20030003464A1 (en) Dual bead assays including optical biodiscs and methods relating thereto
US20050266476A1 (en) Dual bead assays including covalent linkages for improved specificity and related optical analysis discs
WO2002042498A2 (fr) Analyses a l'aide de complexe a deux billes, biodisques optiques, et procedes d'analyse
US7083920B2 (en) Surface assembly for immobilizing DNA capture probes in genetic assays using enzymatic reactions to generate signal in optical bio-discs and methods relating thereto
KR100941416B1 (ko) 바이오 디스크 및 바이오 드라이버 장치 및 이들을 이용한분석방법
JP5161218B2 (ja) 薄膜化学分析装置及びこれを用いた分析方法
WO2003046511A2 (fr) Bio-disques magneto-optiques et systemes utilisant des techniques en rapport
US7033747B2 (en) Multi-parameter assays including analysis discs and methods relating thereto
KR100830926B1 (ko) 바이오 디스크 및 바이오 드라이버 장치 및 이들을 이용한분석방법
US20160349253A1 (en) Reagent storage in an assay device
US20020168652A1 (en) Surface assembly for immobilizing DNA capture probes and bead-based assay including optical bio-discs and methods relating thereto
EP1097378A2 (fr) Dispositifs de dosage utilisant des disques optiques et methodes correspondantes
WO2002071929A2 (fr) Utilisation de procedes mettant en oeuvre des enzymes de restriction et d'autres composes chimiques pour diminuer la fixation non specifique dans des essais sur double bille et biodisques apparentes, procedes et dispositifs servant a detecter des cibles medicales
IL127938A (en) A device with a main signal fixed for diagnostic applications and a test method
JP2011017707A (ja) 生物学的サンプル材料のアーカイブ及び臨床分析用のバイオチップ
US20040248093A1 (en) Magneto-optical bio-discs and systems including related methods
WO2002073605A2 (fr) Essai biologique a deux perles utilisant des espaceurs clivables et/ou la ligature pour ameliorer la specificite et la sensibilite, procedes et dispositifs associes
JP2006505766A (ja) 分析ディスクを含むマルチパラメータ検定とその関連方法
US20050214827A1 (en) Assay device and method
US20050069923A1 (en) Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP